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Numerical and Experimental Investigations of Pulsatile Blood 
Flow through a Dysfunctional Mechanical Heart Valve 
 
Othman Ahmed Smadi, Ph.D. 
Concordia University, 2011 
 
Despite the marked improvement in prosthetic heart valve design and functionality, 
thromboembolism, structural failure, endocarditis and hemolysis are still possible 
complications. In such cases, native heart valve disease is replaced with “prosthetic heart 
valve disease”. Bileaflet Mechanical Heart Valve (BMHV) dysfunction can cause serious 
and potentially fatal complications. 
In vivo, in vitro, and Computational Fluid Dynamics (CFD) studies were conducted on 
dysfunctional BMHVs in order to: (1) investigate the relationship between blood flow 
patterns downstream of the dysfunctional BMHV and the levels of hemolysis and/or 
thrombus formation; (2) to evaluate the limitations of the hemodynamic parameters and 
cutoff values suggested by the American Society of Echocardiography (ASE) guidelines; 
and (3) to improve the accuracy of the current diagnosis methods using the same clinical 
modalities and settings.  
Pulsatile two-dimensional and two phase flow numerical simulations revealed that the 
flow upstream and downstream of a dysfunctional mechanical heart valve was highly 
influenced by dysfunction severity and this resulted in discrepancies between Doppler 
echocardiography and numerically derived transvalvular pressure gradients. Moreover, 
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the flow downstream of the dysfunctional valve was characterized by abnormally 
elevated shear stress and large-scale vortices. These flow characteristics can predispose to 
blood components damage.  
Three-dimensional Fluid-Structure Interaction (FSI) numerical modeling showed that the 
flow nature is three-dimensional and time dependent, especially with the existence of 
valve dysfunction. A pulsatile 3-D FSI numerical model should be used when the 
evolution of the vortical structure downstream of the BMHV is the objective of the study. 
Only flow characteristics through the central orifice are measured by the current 
diagnosis methods. Therefore, revisiting the assumptions and the theory behind the 
current clinical method is critical in order to include the flow through the two lateral 
orifices. 
A practical mathematical model was proposed for predicting the normal reference values 
of Doppler-derived parameters for BMHVs. The new theoretical model overcomes the 
shortcomings of the parameters suggested by the ASE guidelines by taking into account 
flow conditions (Left Ventricle Outflow Tract (LVOT) measurements), valve size and 
valve type.  The accuracy of diagnosis significantly improved using the new theoretical 
parameters compared to those suggested by the ASE. Finally, the new method improved 
the way to evaluate of the performance of BMHVs, not only after implantation, but also 
early during the stage of design and manufacturing. 
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According to the American Heart Association, the prevalence of valve disease in the 
United States reached 2.5% in 2000, amounting to approximately 7 million people.  The 
major problem associated with valve function is their failure to either open fully to allow 
blood to pass smoothly (stenosis) or to close completely to prevent regurgitation of flow 
to the ejection side (incompetence). In severe cases, heart valve replacement is the 
ultimate solution to restore normal function of the heart’s valves. 
 
More than 280,000 heart valve replacements are conducted world-wide each year. 
Almost half of the implanted valves are mechanical heart valves (MHVs) (mainly 
bileaflet mechanical heart valves (BMHVs)) while the remaining half are bioprosthetic 
heart valves (Pibarot and Dumesnil, 2009).  Despite the marked improvement in 
prosthetic heart valve design and functionality, implanted prosthetic heart valves are not 
completely free of complications (i.e., thromboembolism, structural failure, endocarditis, 
and hemolysis) (Vesey and Otto, 2004). In MHVs, thrombus and/or pannus formation are 
major causes of functional stenosis and/or regurgitation (Rizzoli et al., 1999; Roudaut et 
al., 2003).  Prosthetic heart valve dysfunction, in most cases, is lethal, and an early 
diagnosis for prosthetic valve dysfunction is essential for better outcome and successful 
treatment (i.e. heparin, fibrinolysis and reoperation) (Aoyagi et al., 2000; Roudaut et al., 
2007).  
 
Most numerical and experimental studies of BMHVs have focused on normally 
functioning valves with an emphasis on the velocity field, transvalvular pressure drop and 
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blood components damage. In previous numerical studies, the flow downstream of a 
normal BMHV was investigated under steady state flow conditions (Ge et al., 2003) and 
pulsatile flow conditions with or without Fluid-Structure Interaction (FSI) (Grigioni et 
al., 2005; Pedrizzetti and Domenichini, 2006; Alemu and Bluestein, 2007). It should be 
noted that in most studies where FSI was considered, the flow through the BMHV was 
assumed to be laminar (Redaelli et al., 2004; Guivier et al., 2007; Dumont et al., 2007). 
Recently, Direct Numerical Simulation (DNS) with fully coupled FSI was performed by 
Dasi et al. (2007), Nobili et al. (2008) and De Tullio et al. (2009). It should be noted, 
however, that the application of DNS to clinical problems is limited due to its high 
computational cost. 
 
Flow disturbances downstream of a normal BMHV are magnified in the presence of 
leaflet prosthesis dysfunction. There are very few in silico, in vitro or in vivo studies 
examining the effects of BMHV dysfunction on flow patterns (Baumgartner et al., 1993; 
Aoyagie et al. 2001; Montorsi et al. 2003; Smadi et al., 2009). 
 
In the clinical setting, Doppler echocardiography, cinefluoroscopy and computed 
tomography (CT) are the most commonly used modalities for the assessment of 
prosthetic heart valve performance. Due to the risks associated with X-ray exposure, 
Doppler echocardiography is routinely used as a first choice in the evaluation of 
prosthetic heart valve performance. Only patients suspected of prosthetic valve 
dysfunction in Doppler echocardiography are sent to cinefluoroscopy or CT for 
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visualization of prosthetic valve leaflet morphology and mobility (Montorsi et al., 2003, 
Cianciulli et al., 2005; LaBounty et al., 2009).  
The main challenge in echocardiography is the limited capacity of visualization. In the 
aortic position, the clear visualization of aortic prosthetic valves using transthoracic 
Doppler echocardiography (TTE) and/or transesophageal Doppler echocardiography 
(TEE) is limited due to intense echo reverberations and shadowing caused by valve 
components. (Khandheria et al., 1991; Mohr-Kahaly et al., 1993; Maslow et al.  2000; 
Aslam et al., 2007). Therefore, the prosthetic valve evaluation process, using TTE as a 
first choice modality, can only rely on Doppler-derived parameters (peak 
velocity/gradient, mean pressure gradient, effective orifice area (EOA) and Doppler 
velocity index (DVI)) (Vesey and Otto, 2004; Zoghbi et al., 2009; Bach, 2010).  
 
Motivation  
Bileaflet MHVs have been the subject of many recent studies due to their wide use.  
Bileaflet MHVs produce non-physiological flow due to their design compared to natural 
valves (three orifices instead of one orifice in the natural heart valve). Most studies have 
focused on investigating the performance of normal (healthy) MHVs.  
One of the main issues that have not been investigated is the probability and the severity 
of clinical complication (i.e. thrombus formation, left ventricle function) associated with 
the presence of bileaflet MHV dysfunction. In addition, current in-vitro methods appear 
to be inferior at predicting flow or acquiring quantitative information within the valve 
housing or near the wall.  Thus, there is a need to perform numerical simulations in order 
to better understand the dynamics of blood flow through MHVs.  Furthermore, there is a 
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need to assess the diagnostic accuracy and the limitations of current non-invasive 
hemodynamic parameters.  
Objective and Organization 
Based on the literature review presented in chapter 1, the main objectives for the current 
study are: 
1. To investigate the relationship between blood flow patterns downstream of the 
dysfunctional BMHV and levels of hemolysis and/or thrombus formation. 
2. To evaluate the limitations of the hemodynamic parameters and cutoff values 
suggested by the American Society of Echocardiography (ASE) guidelines. 
3.  To improve the accuracy of current diagnostic methods using the same clinical 
modalities and settings. 
 
The thesis is comprised of five chapters.  The first chapter consists of a literature review 
of the main published works on mechanical heart valves (clinical and engineering 
articles) as well as current ideas and challenges in the field. In chapter two, potential 
clinical complications associated with the dysfunction of bileaflet mechanical heart 
valves using 2-D two phase numerical simulations and in vitro tests are investigated. The 
impact of the simplifications made in chapter two on the clinically-related results are 
addressed in chapter three by simulating 3-D FSI models with a realistic aortic root. In 
chapter four, the performance of different Doppler-echocardiographic parameters 
suggested by the guidelines of the American Society of Echocardiography (ASE) on 
identifying the dysfunction of mechanical prosthetic valves in the aortic position is 
investigated. For this purpose, intensive in vitro studies were performed using a custom-
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made cardiac simulator and a clinical echocardiography machine. In addition, in vivo data 
was acquired to validate the in vitro findings. In chapter five, a mathematical model that 
is able to predict the normal reference values of Doppler-derived parameters by 
considering flow conditions, valve size, and valve type is proposed. The theoretical 
results are validated against in vitro results. Moreover, in vivo data from a combined 
echocardiography/fluoroscopy study are extracted and analyzed to validate the theoretical 
predictions. The conclusion of our study and recommendations for future work are 












Numerous studies have been conducted on mechanical heart valves (MHV) to determine 
the nature of blood flow and potential medical complications. The results of these studies 
are presented in this chapter and analyzed in terms of material, design, hemodynamic 
parameters, medical complications and performance diagnosis.  
The studies are divided into two main categories: numerical studies and experimental 
studies. 
 
1.1 Numerical Studies  
Computational Fluid Dynamics (CFD) are widely used to investigate blood flow through 
MHVs. Currently available MHVs do not mimic the native heart valve (fig. 1.1), and 
generally produce non-physiological flow. Due to the complex nature of the non-
physiological flow produced by MHVs, different assumptions have been considered. The 
laminar assumption has been used to simulate the pulsatile nature of the cardiac cycle due 
to the absence of a numerical model capable of covering the laminar, transitional and 
turbulent regimes. The development of the low Reynolds Wilcox ( k ) model (Wilcox 
1998) encouraged researchers to simulate the pulsatile flow under the turbulent regime 
assumption. In addition, the fluid-structure interaction (FSI) between valve leaflets and 
blood flow has been studied to include the effect of blood flow on the leaflet and vice 
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versa.  Due to the dramatic increase in the computational power and memory of 
computers, Direct Numerical Simulations (DNS) were recently introduced to simulate 
blood flow through the entire cardiac cycle with strongly coupled FSI simulation (De 
Tullio et al., 2009).  
 
1.1.1 Laminar Blood Flow  
A comparison between 3-D numerical simulations for a bileaflet valve and experimental 
studies using Laser Doppler Anemometry (LDA) measurements was performed by King 
et al. (1997). The group considered only a quarter of the geometry by applying two 
planes of symmetry. The nature of flow was unsteady and laminar. The aim of this study 
was to validate the CFD solution and to get the optial opening angle for the leaflet. 
Significant differences between CFD and LDA were found and were explained by 
limitations in CFD itself. However, good agreement was found between the numerical 
and the experimental results in terms of the quality and behaviour of the flow, including 
the existence of vortex shedding downstream of the valve and the presence of slow 
moving fluid in the sinus area.  Finally, the authors concluded that numerical simulations 
were able to predict the flow characteristics downstream of a MHV and can be used to 
improve the design of future MHVs. 
 
Figure 1.1 Schematic of the St. Jude Medical valve with leaflets shown in open and 
closed (dotted line) positions (Dasi et al., 2007). 
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A new technique for moving mesh was proposed by using multi-zone unstructured 
moving grid schemes by Shi et al. (2003). In short, the mesh was created for the entire 
geometry without considering the solid domain (the leaflets) and once the leaflet position 
was calculated, the nodes in contact with the solid phase were considered as a moving 
boundary for the solid phase. The CFD results showed that the leaflet tip is the most 
sensitive region for hemolysis due to high velocity and the presence of a velocity gradient 
near the tip.  
 
The Arbitrary Lagrangian Eulerian method (ALE) was used by Dumont et al. (2004). 
They used FLUENT (commercial software) and the ALE method to implement FSI to 
MHV 2-D unsteady (pulsatile) laminar flow conditions. They compared their results with 
a CCD camera to record the valve positions at different instants. User defined function 
(UDF) was used to write an external code to describe the leaflet motion and a dynamic 
mesh was used to redefine the mesh with each small movement of the solid boundaries. 
The authors concluded that the simulation gave good agreement with the experimental 
results. 
 
3-D pulsatile blood flow through a St. Jude HP 27 bileaflet valve was simulated by 
Redaelli et al. (2004). Only a part of the systolic phase was considered to simulate the 
valve opening process. They used a user defined function and a laminar model to 
implement FSI using FLUENT. In parallel, experimental work using a high speed camera 
was performed to validate the numerical simulations of the MHV opening process by 
considering the same valve design and the same inlet condition. A good agreement was 
found between numerical and experimental results. Further improvements to the current 
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model were suggested including the consideration of normal flowrate and the transitional 




(2003) investigated grid resolution and flow symmetry, focusing mainly on grid 
resolution and its effect on the accuracy of the results obtained using CFD. For this 
purpose, 3-D, steady and fully developed flow through a St. Jude bileaflet mechanical 
heart valve was simulated for different Reynolds (Re) numbers. They concluded that the 
results are very sensitive to mesh independence under physiological conditions. 
Furthermore, they questioned the validity of a symmetrical model assumption, since they 
found that asymmetry in the flow can appear for Re as low as 120, even though the flow 
was assumed laminar and steady. 
 
The flow through a St. Jude bileaflet heart valve in the aortic position with co-existing 
subaortic stenosis was investigated by Guivier et al. (2007). 2-D laminar and pulsatile 
flow simulations were performed by taking into account the fluid-structure interaction 
effect. The study concluded that, under such conditions, the major jet flow moves 
towards the lateral orifice rather than the centre. Furthermore, the leaflet close to the 
subaortic stenosis will not work properly.  Therefore, more awareness should be 
considered by clinicians to align the echo-Doppler beam to avoid an underestimation of 
the effective orifice area of the valve. 
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Recently, Guivier-Curien et al. (2009) extended their 2-D model to a 3-D fluid-structure 
interaction model. They simulated blood flow through a 27 mm St. Jude prosthetic heart 
valve and validated the numerical results using 2-D PIV. However, the study had one 
important limitation which is adapting a maximum flowrate equal to only one third (~8 
L/min) of the actual normal flowrate (~25 L/min). This modification was necessary in 
order to obtain a laminar flow that is far from the physiological blood flow, especially 
when MHV is present. A strongly coupled FSI was adapted. Five different time instants 
including, acceleration, deceleration and peak of the systolic phase were analyzed. The 
axial velocity vectors and the leaflet dynamics (opening and closure) from the 
experimental and numerical measurements were compared and good agreement was 
found between both studies. 
 
1.1.2 Turbulent Flow  
Peacock et al. (1997) investigated the onset of turbulence under pulsatile flow conditions 
in a straight tube and correlated the results to flow conditions in the human aorta 
downstream of the aortic heart valve. They suggested that the onset of turbulence in the 
human aorta is highly possible. However, by implanting the mechanical heart valves, the 
flow downstream of the mechanical heart valve was highly disturbed and the turbulent 
flow became dominant during the peak and deceleration stages of the systolic phase (Liu 
et al., 2000). Therefore, in order to extract useful clinical information (i.e., threshold of 
platelet activation and/or blood hemolysis), simulating turbulent blood flow through the 
mechanical heart valve is essential, especially at the physiological flowrate.   
 
 




Bluestein et al. (2000) numerically and experimentally investigated the occurrence of 
thromboembolic complications caused by normally functioning bileaflet mechanical heart 
valves. A time dependent numerical study was performed using Wilcox k  turbulence 
model for internal flow with low Reynolds number. Digital Particle Image Velocimetry 
(DPIV) was also conducted under the same conditions. The comparison between 
numerical and experimental results showed the ability of the Wilcox k  model to 
simulate blood flow through a bileaflet mechanical heart valve. In addition to blood 
contact with foreign material, non-physiological blood flow through the three valve 
orifices introduced vortex shedding downstream of the valve leaflets which in turn played 
an important role in cerebrovascular micro emboli formation. Moreover, the shedded 
vortices could cause platelets to aggregate. Long residential times with high levels of 
shear stress were noticed during the vortex shedding process.  
 
The effects of surgical implantation techniques and valve orientation on blood 
hemodynamics in the valve’s wake position were studied by Bluestein et al. (2002). Time 
dependent Computational Fluid Dynamic (CFD) simulations using the Wilcox k  
model for blood flow with low Reynolds number was conducted on commercial software 
(FLUENT). The mesh quality near the wall was made fine to maintain 1y  (
y  is the 
non-dimensional viscous sub layer height). The simulation did not consider fluid-
structure interactions between the leaflets and the blood, and the valve leaflets were fixed 
in the fully open position. The study concluded that heart valve misalignment has an 
important effect on elevating platelet activation and thromobembolism formation.  
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An in-vitro study was conducted by Yin et al. (2004) on two different MHVs: Bileaflet 
(CarboMedics) and monoleaflet (Bjork-Shley) valves. In addition, numerical simulations 
using Wilcox k  model for transitional/turbulent flow under pulsatile flow were 
conducted. To measure the shear stress histories of the platelets, numerically, the 
Lagrangian approach for particulate two phase flow was used to calculate, approximately, 
the separated trajectories of platelets that were close to the valve leaflets. 
Thromboembolism phenomenon in both MHVs was noticed. Experimentally, the platelet 
activation states were two times higher in bileaflet valve than in the monoleaflet valve. 
Furthermore, the numerical results showed that the shear stress magnitude could be more 
than four times higher in bileaflet valves.  
 
In 2005, Ge et al. extended their previous work (Ge et al., 2003) by increasing the 
flowrate to near-peak systole flowrates.  The flow was fully turbulent with Re as high as 
6000. Two Re numbers were chosen to be modeled, Re = 750 and Re = 6000. For 
laminar flow, the Direct Numerical Simulation (DNS) was employed. For turbulent flow, 
two different models were used (the Reynolds-average Navier-Stokes approach 
(URANS) and the Detached Eddy Simulation approach (DES)). The DES method is a 
hybrid technique proposed as a precise approach for predicting separated flows. It 
combines two concepts: URANS for the entire boundary layer and Large Eddy 
Simulation (LES) for the separated regions.    
To validate their numerical results, they performed experimental measurements using 
Particle Image Velocimetry (PIV) under the same conditions. For laminar flow, good 
agreement between numerical and experimental results was observed and the 
unsteadiness of flow was noticed as early as for Re = 350. The DES approach was 
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recommended to study flow in the sinus region as opposed to the URANS approach. 
URANS showed steady, stable and ring-shaped vortices. On the other hand, DES showed 
a very complex flow with multiple eddies. The damaging of red blood cells has a direct 
relation with the number and the form of eddies generated downstream of the valve. For 
DES results, red blood cells remain for less time inside the vortical field and therefore 
cause lower blood elements damage.  
 
Direct Numerical Simulation (DNS)  
Dasi et al. (2007) studied blood flow through a 23 mm regent St. Jude medical heart 
valve assuming DNS model and using 10 million nodes and a time step of 0.1 ms. An 
immersed boundary method was used to track the leaflet movements. The numerical 
results were validated against 2-D PIV measurements. The comparison was made about 
the vorticity magnitude and its evolution during the systolic phase. Good agreement was 
found during the acceleration part of the systolic phase. In the meantime, less accurate 
agreement was found during the peak and deceleration periods of the systolic phase 
where the turbulent nature persisted until the late stage of deceleration.   
 
In order to confirm the accuracy of the simulations numerically, the dynamics of the 
valve leaflets, Nobili et al. (2008) were studied using the ALE method with commercial 
software (FLUENT) and user-defined functions in order to simulate the flow through a 
model of 27 mm St. Jude HP mechanical heart valve using strongly coupled FSI.  The 
validation for the numerical simulations was done for the leaflet dynamics and the 
instantaneous transvalvular pressure gradient through the valve.  The simulation 
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consisted of 2.1 million elements and a time step of 0.2 ms. Furthermore, only two cycles 
were simulated to guarantee cycle independence. 
 
Recently, De Tullio et al. (2009) simulated blood flow through a 27 mm Sorin-Bicarbon 
bileaflet mechanical heart valve using the immersed boundary method with Direct 
Numerical Simulation (DNS). Even though 2.5 million nodes had good accuracy, 6.6 
million nodes were adapted for the entire domain. Also, the angular velocity of the 
leaflets was used to check the convergence with a residual error of approximately 10
-4
. 
This could raise questions on the validity of such criteria during the stationary status of 
the leaflets (around the peak of the systolic phase and during the complete diastolic 
phase). However, different time instants were depicted during the systolic phase to 
validate the numerical results using 2-D PIV measurements. Good agreement was found 
during early stage acceleration, while a less comparative agreement was observed during 
the deceleration phase. This could be interpreted as a shortcoming of the statistical 
average for the numerical simulation as, only, 10 cycles were averaged compared to 200 
cycles in the PIV measurements.  The opening and closure dynamics in the numerical 
simulations were in very good agreement with the experimental findings. The leaflets 
were allowed to move in two axial and rotational directions. The asymmetric orientation 
for the valve and the sinuses create a significant difference between the two leaflets 
dynamics (the upper leaflet (close from the sinus valsalva) had a 20 ms closing delay 
time compared to the lower one). Finally, the authors found that the 2-D turbulent shear 
stress calculations underestimated the turbulent shear stress magnitude especially in the 
sinus area where the flow is highly three dimensional. 
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1.2 Experimental Studies  
Various clinical in-vivo techniques have been introduced to explain the nature of flow 
and to evaluate heart valve performance including echocardiography, catheterization and 
Magnetic Resonance Imaging (MRI). Catheterization is an inadequate method to be used 
for MHV flow analysis (Fukumoto et al., 2003), while echocardiography and MRI 
represent appropriate techniques for diagnosis. Moreover, these techniques, as well as 
more advanced techniques such as Particle Image Velocimetry (PIV) and Laser Doppler 
Anemometry (LDA) have been used in-vitro to verify the accuracy of in-vivo diagnosis 
methods and to clarify the nature of the flow downstream of MHVs (Liu
 
et al., 2000; 
Grigioni
 
et al., 2001; Brucker et al., 2002).  
 
Validation of different techniques through in-vitro studies has been studied by different 
authors. Browne et al. (2000) attempted to demonstrate the difference between LDA and 
PIV. Steady flow measurements near peak systole were carried out through a St. Jude 
bileaflet MHV in the aortic position. In addition, maximum turbulent shear stress and 
maximum turbulent principal stress were studied and compared. Large differences in 
values and trends (up to 200%) between the two methods were shown. A combination of 
the two techniques was recommended by using PIV to describe the general flow patterns 
and using LDA in specific areas to get more detailed and accurate results.  
 
1.2.1 Laser Doppler Anemometry (LDA) 
Laser Doppler Anemometry (LDA) was used experimentally to investigate turbulent flow 
characteristics downstream of different types of bileaflet valves by Liu et al. (2000). St. 
Jude Medical valves, in addition to CarboMedics and Edwards Tekna valves, were 
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selected for investigation. The maximum turbulent normal and shear stresses were found 
to be 7.8 mm downstream of the valve. For the St. Jude bileaflet valve, the maximum 




and the maximum Reynolds shear 
stress was 510 dyn/cm
2
 (51 Pa). Higher values for the CarboMedics bileaflet valve were 





(68 Pa), respectively. The highest value for Reynolds stress was 
obtained from the Edwards Tekna bileaflet valve, where the Reynolds normal stress was 
2630 dyn/cm
2
 (263 Pa) and the Reynolds shear stress was 770 dyn/cm
2
 (77 Pa). The 
valve’s exposure time was very similar for all three types, and ranged from 1-10 ms. 
Moreover, the Kolmogorov length scale (the size of the smallest eddies that are 
responsible for dissipating the energy) of the three valves ranged from 20-70 m . As the 
size of the smallest eddy is significantly larger than the size of a red blood cell, it creates 
less damage than eddies of sub-cellular scale. Finally, the authors concluded that such 
combination of turbulent stress, exposure time and Kolmogorov scales could initiate 
blood cells damage.  
 
Lu et al. (2001) re-evaluated and discussed the reference work by Sallam and Hwang 
(1984). Sallam and Hwang (1984) claimed that hemolytic thresholds for red blood cell 
damage in turbulent flow were equal to 400 N/m
2
 and 1 ms for turbulent shear stress and 
exposure time, respectively. However, by using the same method and two-component 
LADA, the new suggested values by Lu and co-workers for hemolytic thresholds were 
found to be 800 N/m
2
 and 1 ms. Moreover, Kolmogorov length scales were estimated to 
be around 9 m  which is on the same order of magnitude as the size of red blood cells.  
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Grigioni et al. (2001) focused on the leaflet design in bileaflet valves in terms of flow 
characteristics and turbulent shear stress levels. The authors studied a Sorin Bicarbon 
(SB) valve (curved leaflet) and a St. Jude valve (straight leaflet). The same diameter and 
flow conditions were considered and the velocity profiles for four different positions 
downstream of the valves were measured. Laser Doppler Anemometry (LDA) was used 
to measure the velocity profiles downstream of the valves. Significant differences for 
velocity profiles were observed between the two valves. High shear rates were observed 
for the SB, but for shorter duration compared to the St. Jude valve, in which lower shear 
rates with longer residency time are observed. They suggested that the design of the SB 
valve should be improved to reduce thrombus formation. 
 
1.2.2 Particle Image Velocimetry (PIV) 
Brucker (1997) was able to measure a relatively high velocity magnitude using a dual-
camera DPIV. The two cameras (master and slave) record a specific illuminated plane 
with a controlled time delay between both of them. Then, a frame-by-frame cross 
correlation is made. This method is good when the pulsed and synchronized illumination 
is not available and the method is also independent of recording frequency. Two different 
prosthetic valves were tested under the same flow conditions. One valve is the Bjork 
Shiley monoleaflet mechanical heart valve and the other is the Sorin-Bicarbon bileaflet 
mechanical valve. A frame rate of 50 Hz and a time delay of 0.2-0.3 ms, was enough to 
capture the strain rate as well as the vortex formation downstream of the valves.  
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A new tri-leaflet MHV in aortic position was studied by Bucker et al. (2002) using 2-D 
Digital Particle Image Velocimetry (DPIV). In addition, a high speed camera was used to 
capture the leaflet motion during the cardiac cycle. The study showed good consistency 
between the new MHV and the native valve in terms of flow nature and leaflet closing 
and opening phases.  
 
The flow patterns downstream of an artificial bileaflet heart valve were investigated by 
Balducci et al. (2004).  A 2-D PIV with Particle Tracking Velocimetry (PTV) was used to 
estimate the level of shear stress and the particle residential time, respectively. The mean 
flowrate was 1 L/min (Vmax = 0.625 m/s).  The authors confirmed the importance of 
combining PTV with the PIV in order to calculate the blood elements’ residential time as 
well as the level of shear stress. The level of shear stress was found to be below the 
threshold for red blood cells damage. 
 
Using Viscous Shear Stress (VSS) and/or Reynolds Shear Stress (RSS), to investigate the 
damage of blood elements, is controversial. Therefore, Ge et al. (2008) attempted to 
study the physical differences between both parameters. Their study was conducted using 
2-D high-resolution velocity measurements with a PIV system. The PIV results were 
compared with 3-D FSI numerical results extracted from Dasi et al. (2007). The blood 
hemodynamics through a St. Jude 23 mm regent bileaflet mechanical heart valve were 
investigated. The highest Reynolds Shear Stress (RSS) and Viscous Shear Stress (VSS) 
values were found during the acceleration phase.  The minimum Kolmogorov scale was 
42 µm. This is significantly larger than the red blood cells scale (~ 7 µm). A significant 
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difference, in terms of magnitude and location, between the RRS and VSS downstream of 
the bileaflet valve were found. The study concluded that the RRS is not an adequate 
physical representative to the level of blood elements damage. 
 
The levels of turbulent and viscous shear stress, for the region downstream of a St. Jude 
Medical 27 mm bileaflet valve, was investigated by Li et al. (2010) using 2-D DPIV.  
Due to the limitation in the spatial resolution of the DPIV measurements, the dynamic 
equilibrium between the resolved and the Sub-Grid-Scale (SGS) energy flux was 
adopted. The Turbulent Viscous Shear Stress (TVSS), which is proportional to the square 
root of Reynolds Shear Stress (RSS), was calculated. The magnitude of both RSS and 
TVSS were 80 and 12 N/m
2
, respectively. They found the shear stress values were 
significantly lower than the threshold for damaging red blood cells. 
 
Kaminsky et al. (2007) studied the importance of the out-of-plane velocity component 
downstream of two different prosthetic heart valves (ATS bileaflet valve and monoleaflet 
valve) using 3-D time resolved (3000 images /second) PIV measurements.  They showed 
that the third velocity component had a minimal impact on the velocity magnitude. 
However, the third velocity component was more significant in the mono-leaflet case 
compared to the bileaflet valve, especially around the trailing edges of the leaflets and 
inside the valsalva sinuses.   
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1.2.3 In Vivo Diagnostic Parameters  
A list of the most important parameters for evaluation of bileaflet MHVs was given in the 
recent review papers by Zoghbi et al. (2009) and Bach (2010). In both papers, the authors 
gave the definition for each parameter and proposed a new procedure for evaluating 
MHVs (Table 1.1).  
Effective Orifice Area (EOA) and Energy Loss Coefficient (ELCo) are parameters for 
calculating the area of the heart valve.  The ELCo parameter is associated with the 







                                                                                      (2.1) 
where AoA is the cross-sectional area of the proximal ascending aorta.  
Doppler Velocity Index (DVI) is the ratio of the left ventricle outflow tract velocity to the 
maximum velocity through the heart valve.  
 
 It is worth noting that the parameters being used for evaluating bileaflet MHVs (3 
orifices) are exactly the same as for the native heart valves (single orifice). Therefore, all 
parameters and equations are derived based on assuming the existence of only one orifice 
(the central orifice) for the MHV as well as for the native valve.  
Some remarks on the use of current diagnostic techniques are highlighted below. 
Most parameters are valve size dependent except the Doppler Velocity Index (DVI). 
Generally, the Effective Orifice Area (EOA) and the Energy Loss Coefficient (ELCo) are 
proportional to valve size. Therefore, only the combination of valve size and the 
parameter value are useful. However, published works on the reference values for 
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different parameters are inconsistent with each other. (Zoghbi et al., 2009; Rosenhek et 
al., 2003).  Moreover, the two lateral orifices are not included in the calculations or taken 
into account in the evaluation process. Hence, the physical flow through the complete 
MHV is not accurately represented in the current methods. Therefore, revisiting the 
assumptions and the theory behind current methods are critical in order to include the 























-Peak pressure gradient is less 
accurate than the mean ( left 






-EOA < 0.8 cm
2
 ( significant 
stenosis ) 
 -Depends on the ability of 
measuring the left ventricle 










-DVI < 0.25 (significant 
obstruction). 
-Sensitive only to severe 
stenosis. 








-Accounts for pressure 
recovery phenomenon. 
- Usually > EOA (Garcia et 
al., 2000) 
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The main conclusions of the literature review could be addressed based on the used 
methods (numerical studies and experimental studies). 
 
The main conclusions from the numerical studies could be addressed as follows:  
1. Among different prosthetic heart valves, bileaflet MHV was the main subject of 
recent studies (the most implanted prosthetic valves). 
2. The laminar assumption is not adequate for representing the physiological flow. 
Although it can be included to depict the features of the main flow features, the 
results cannot be used to give an accurate correlation between the pathological 
conditions and the simulated flow. Therefore, it is highly recommended to avoid 
using the laminar assumption when possible. 
3. The turbulence models (especially k-w and LES models) were significantly better 
at simulating physiological flowrate range compared to the laminar model. The 
models are often used for validation against PIV, LDA and MRI. 
4. Recently, with a significant improvement in computer technology and parallel 
computing, the DNS became achievable with reasonable accuracy. 
5. It is worth noting that the majority of the studies are dedicated to investigate the 
performance of normal (healthy) MHVs. However, it is important to evaluate the 
dysfunctional MHVs as well. 
 
The main conclusions from the experimental studies can be addressed as follows:  
1. Clinical complications (i.e., thrombus formation, left ventricle function) due to the 
presence of bileaflet dysfunction in mechanical heart valves have not been 
investigated yet. 
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2. The above in-vitro methods appear to be inferior in predicting flow or acquiring 
quantitative information within the valve housing or near the wall and the need 
for numerical simulation arises as a promising tool for better understanding the 
dynamics of blood flow through MHVs.  
3. The diagnostic parameters for the native aortic heart valve are being used for the 
mechanical valves as well. However, using the parameters for MHVs is not as 
accurate as using them with the native heart valves. Many limitations (i.e., flow 
and valve size dependence) were mentioned in the literature and the need for new 
diagnostic parameters is essential. 
4. Using 3-D PIV for testing a dysfunctional mechanical heart valve is necessary 
(the out of plane velocity component is expected to have a significant contribution 











Potential Clinical Complications Associated With Dysfunction 
of Bileaflet Mechanical Heart Valve: CFD and In Vitro Study 
 
 
In the current chapter, the clinical consequences of the presence of Bileaflet Mechanical 
Heart Valve (BMHV) dysfunction was explored in terms of level of damage for the 
bloods elements (e.g, platelet activation), and also, the impact of such dysfunction on the 
accuracy of Doppler measurements (peak velocity, mean pressure gradient, and peak 
pressure gradient).  The current point of research was approached numerically 
considering two phase flow and using pulsatile 2-D turbulence model. Also in vitro test 




Dysfunction of Bileaflet Mechanical Heart Valve (BMHV) is a serious and potentially 
fatal complication. The incidence of dysfunction with this type of prosthesis is 0.2–6% 
patients/year (Montorsi et al., 2003). The restriction of the motion of the leaflet(s) may be 
due to pannus in-growth (prevalence 0.14–0.65% patients/year (Sakamoto et al., 2006)) 
and/or thrombus formation. Several non-invasive medical imaging modalities, including 
Doppler echocardiography, magnetic resonance, computed tomography, and 
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cinefluoroscopy may be used to detect BMHV dysfunction and quantify its severity. 
However, these modalities have important limitations from theoretical, technical, and 
logistic standpoints. In particular, it is often difficult or impossible to discriminate with 
the currently available diagnosis techniques, a normally functioning BMHV from a 
dysfunctional BMHV with mild severity that may become life-threatening in the short-
term (Pibarot and Dumesnil, 2009). Moreover, the potential impact of a dysfunctional 
BMHV on blood components (red blood cells, platelets and coagulation factors) remains 
relatively unexplored. 
Most previous numerical and experimental studies of BMHVs have focused on normally 
functioning valves with an emphasis on the velocity field, transvalvular pressure drop and 
blood components damage. In previous numerical studies, the flow downstream of a 
normal BMHV was investigated under steady state flow conditions (Ge et al., 2003) and 
pulsatile flow conditions with or without Fluid-Structure Interaction (FSI) (Grigioni et 
al., 2005; Pedrizzetti and Domenichini, 2006; Alemu and Bluestein, 2007). It should be 
noted that in most studies where FSI was considered, the flow through the BMHV was 
assumed to be laminar (Guivier et al., 2007; Redaelli et al., 2004; Dumont et al., 2007). 
Recently, Direct Numerical Simulation (DNS) with fully FSI was performed by Dasi et 
al. (2007) and Nobili et al. (2008). It should be noted, however, that application of DNS 
to clinical problems is limited due to its high computational cost. 
Most numerical and experimental studies on BMHV showed that the flow is 
characterized by trailing vortices arising from the leaflets and high levels of turbulent and 
wall shear stresses, usually many times higher than the physiological ones (Ge et al., 
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2005;  Ge et al., 2008;  Dasi et al., 2007), potentially leading to blood component 
damage. 
The disturbances of flow downstream of a normal BMHV should be magnified in the 
presence of leaflet prosthesis dysfunction. There are very few in silico or in vitro studies 
examining the effect of BMHV dysfunction on flow pattern. Baumgartner et al. (1993) 
showed, in vitro, that a dysfunctional BMHV (Carbomedics valve with one leaflet 
blocked) leads to an increase in the energy loss through the valve and a significant 
difference between Doppler and catheter gradients. This was confirmed numerically in a 
recent study performed by Smadi et al. (2009). 
The objective of this study is to numerically and experimentally investigate the pulsatile 
turbulent flow downstream of a dysfunctional BMHV in terms of velocity field, diagnosis 
limitations and potential negative effect on blood components. 
 
2.2 Models and Methods 
2.2.1 Numerical Method 
Five 2-D 25 mm St. Jude Medical Hemodynamic Plus valve models were created for the 
purpose of this study. The restriction of the leaflet motion was applied only on one of the 
2 leaflets (as it often occurs in the clinical setting). The position of the leaflet was varied 
from the fully opened position (opening angle = 85
o
; normal function) to the fully closed 
position (angle = 30
o
; 100% dysfunction) with three equally spaced intermediates. It 
should be noted that the current study focuses only on dysfunction affecting only one 
leaflet, given that this is the most frequent situation in the clinical setting and that it is 
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more difficult to detect when compared to the situation where both leaflets have restricted 
motion (Montorsi et al., 2003). 
 
The simulations were performed under unsteady state conditions with an experimental 
pulsatile flow as inlet condition (Fig. 2.1) and ambient pressure at the outlet. The mean 
cardiac output was 5 L/min and the heart rate was 70 bpm (systolic phase duration 0.3 s). 
Blood was simulated as a Newtonian fluid with a density of 1060 kg/m
3
 and a dynamic 
viscosity of 0.0035 Pa s. The assumption of a Newtonian fluid behavior is realistic for 
blood flow in large arteries such as the aorta (Morris et al., 2005). The inlet conditions 
corresponded to a Remax = 7969, Reaverage = 3820 and Womersley number = 16.2. 
 
 
Figure 2.1 Models for the five different cases: 1) 0% dysfunction; 2) 25% dysfunction; 3) 
50% dysfunction; 4) 75% dysfunction; 5) 100% dysfunction.  
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The Wilcox’s low-Reynolds model (Wilcox, 1998) was used to simulate the flow during 
the complete cardiac cycle. However, the interaction between the valve leaflets and the 
fluid was not considered. As a consequence, the opening and closure dynamics were not 
simulated properly in this study. Therefore, only the fully opening period (from 60 ms to 
250 ms) was analyzed in the results section (Alemu and Bluestein, 2007). 
Commercially available software (Fluent 6.3.26 - Fluent Inc.; Lebanon; NH; USA) was 
used to perform the numerical simulations. Although blood flow through a BMHV is 
characterized with laminar-transitional-turbulent behavior, the Wilcox’s low-Reynolds 
model was found able to accurately predict its main flow characteristics (Bluestein et al., 
2000). 
Turbulence Model  
In the present study, time-averaging or Reynolds averaging has been used as a mean of 
analyzing turbulence by separating fluctuating properties with their time-mean values. 
Thus, the true velocity ( iu ) is defined by: iii uuu  , where the overbar refers to time-
average and prime refers to fluctuation from this average. When this is substituted in the 
general Navier-Stokes equations, a new term will be introduced, i.e., the Reynolds 
stresses (
jiuu   ). To close the governing equations with the new extra variables, two-
equation transitional k  model was used through which these Reynolds stresses are 










































                                                           (2.1) 
where iu  is the average velocity in i  direction, tμ  is the turbulent eddy viscosity and k  
is the turbulent kinetic energy.  
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A second-order upwind scheme was selected to be the discretization scheme for the 
convection terms of all governing equations. For all transient calculations, a second-order 
temporal discretization scheme was used. The mass-momentum equations were solved 
using the COUPLED solver and all results were converged to residuals of < 10
-4
, 
unsteady simulation in general required 15-25 iterations per time step. Moreover, 
additional care was taken close to the wall and leaflet surfaces to maintain y
+
 << 1. The 
time step was set to 0.25 ms to satisfy time step independency. Three cycles were 
simulated before starting extraction of the results in order to reach the periodicity. 
 
Discrete Phase Model 
In order to calculate the level of platelet activation (   t ) (summation of shear stress 
magnitude multiplied by the exposure time) across different paths, a Lagrangian approach 
of particulate two phase flow was used. This model has been used and described in 
details by Bluestein et al. (2000).  
Briefly, at each time instant, the absolute value of total shear stress (laminar and 
turbulent) was taken into account using Boussinesq approximation ( vuyu   / ) 
and multiplied by the exposure time ( )t , then the summation of the results of all time 
instants during the selected period was calculated.  
In order to show the effect of valve dysfunction on the platelet activation level, the 
calculations were carried out during the deceleration phase (0 - 50 ms after the peak and 
100 - 150 ms after the peak). Therefore, the results did not depict the platelet activations 
in the entire diastolic phase but rather depicted the platelet activation level wherein flow 
conditions predispose to platelet aggregation (Alemu et al., 2007). 




Steady flow simulations were conducted first to establish the grid density. The 
uncertainty and error in the study was found following the recommendations suggested 
by Celik et al. (2008). Table 2.1 and figure 2.2 show the calculations for the 
discretization error of the maximum velocity value in the entire field and velocity profile 
at the vicinity of the valve, respectively. N is the number of elements, r  is the refinement 
ratio, p  is the apparent order, ext  is the extrapolated value, ae  is the apparent error, exte  
is the extrapolated error and fineGCI  is the fine-grid convergence index. According to the 
maximum velocity in the entire field, fineGCI  was 0.09% which does not account for 
modeling errors. In addition, figure 2.2 shows the axial velocity profile at the vicinity of 
the valve. The local order of accuracy p  ranges from 0.5 to 11 with a global p  average 
1.6. The maximum descretization uncertainty was 6% in the area close from the 
dysfunctional leaflet.  
 
2.2.2 Experimental Method  
In order to investigate the accuracy of the conventional Doppler-echocardiographic 
measurements in detecting the dysfunction of BMHV and also to validate and compare 
some of the results obtained with the numerical study, Doppler echocardiographic 
measurements were performed in a mock flow model incorporating a BMHV with 
various degrees of dysfunction.   
The mock flow circulation model used in this in vitro study has been described and 
validated (Garcia et al., 2003) (Fig. 2.3). The model is mainly made up of a reservoir, a 
compliant aortic chamber and a valve resistance. The flow was provided by a computer  
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Table 2.1 Calculations of discretization error 
)/( smfieldentiretheinvelocityMaximum  
321 ,, NNN  299,848, 177,650, 
100,450 
21r  1.299 
32r  1.3300 
1  2.844237 
2  2.849587 
3  2.879322 
p  5.8921 
21












                                   a)                                                                     b) 
Figure 2.2 (a) Velocity profile at the vicinity of the valve for different grid solutions; (b) 
Fine-grids solution with discretization error bars.  
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controlled DC motor coupled to a gear pump (Vi-CORR, Viking Pump). The left 
ventricular outflow tract and the aorta were both circular and rigid (cross sectional area = 
8 cm
2
). The compliant chamber was located immediately downstream of the proximal 
rigid aorta. The fluid was composed of 2/3 water and 1/3 of glycerol so that its density 
(1080 kg/m
3
) and viscosity (3.5 cP) were similar to that of blood under high shear rate 
conditions. The flowrate was measured by an electromagnetic flowmeter (Cliniflow II, 
Carolina Medical Electronics, accuracy 5% full scale) and the ventricular and aortic 
pressures with Millar catheters (model MPC 500, accuracy 0.5% full scale) under a 
sampling frequency of 1000 Hz. For each experiment, 10 cycles were recorded and the 
average was used to calculate the hemodynamic parameters. 
For all experiments, the transvalvular flowrate was maintained at 5 L/min, corresponding 
to a stroke volume of approximately 70 mL for a heart rate of 70 bpm (ejection phase: 0.3 
s). Systolic and diastolic pressures were maintained under normal conditions: 120 mmHg 
and 80 mmHg, respectively. 
 
 
Figure 2.3 (a) Schematic representation of the mock flow model and the alteration 
mechanism of the lower leaflet opening position using a small stop pin. 
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3.2.2.1 Doppler Echocardiographic Measurements  
Doppler echocardiographic velocity measurements were performed using a Sonos 5500 
(Philips Medical Systems/Agilent Technologies, Andover, Massachusetts) with a probe 
of 2.25 MHz. The probe was oriented to obtain optimal alignment of Doppler beam and 
flow across the central orifice of the BMHV. In order to avoid aliasing, the continuous-
wave Doppler mode was used. The measurements were performed over five to seven 
cycles and averaged. Maximal Doppler-echocardiographic velocity, mean and maximal 
transvalvular pressure gradients (determined using simplified Bernoulli equation) were 
evaluated for the BMHV with 0%, 50% and 100% degrees of dysfunction. These results 
were compared to the ones obtained from the numerical study. 
 
2.3 Results  
2.3.1 Doppler-echocardiographic Measurements  
Figure 2.4a shows the maximum velocity magnitude at the peak of systolic phase for 
different degrees of dysfunction using Doppler-echocardiographic velocity measurements 
and numerical simulation. It should be mentioned that for Doppler-echocardiography, the 
ultrasound beam is usually conically-shaped and its axis was aligned with the central 
orifice (the traditional method). As a consequence, the results obtained using Doppler-
echocardiography for the maximum instantaneous velocities were compared with the 
maximum instantaneous velocity obtained numerically through the entire domain.  
In the healthy model, there was a good agreement between numerical and experimental 
results with percentage of difference less than 1.3%. When a dysfunction was induced on 
the lower leaflet, a discrepancy, proportional to the severity of the dysfunction, appeared 
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between the experimental (Doppler-echo) and numerical results for maximum velocity. 
This difference reached up to 15% for 100% dysfunction.  
Figure 2.4b shows the maximum transvalvular pressure gradient (TPGmax) and mean 
transvalvular pressure gradient (TPGmean), for different percentage of dysfunction. The 
TPGs were determined using the standard simplified Bernoulli equation (TPG = 4V
2
).  
TPGmax is a function of the square of maximum velocity (TPG = 4V
2
max). Therefore, the 
numerical and experimental TPGmax results have the same trend as for the maximum 
velocity but with a magnification of the percent difference (2.6%-32.2%). On the other 
hand, in both 0% and 50% dysfunctions, the numerical TPGmean magnitude was lower 
than the echo-Doppler TPGmean magnitude. This could be explained as a result of the 
absence of FSI in the current numerical simulation. For 100% dysfunction, the FSI effect 
was limited due to movement of only one leaflet and as a consequence the numerical 
TPGmean magnitude was higher than the echo-Doppler one.  
 
2.3.2 Platelet Activation  
Figure 2.5 shows estimated platelet trajectories for different percentages of dysfunction 
downstream of the BMHV during two different periods of the deceleration phase. Figure 
2.5.a shows platelets paths from 0-50 ms after peak systole instant and figure 2.5.b shows 
platelets paths from 100-150 ms after peak systole instant. Eighteen equally spaced 
positions across the valve were selected to inject the platelets at 0 and 100 ms after the 
peak and the results were depicted after 50 ms from the injection time. 
 
 




Figure 2.4 Comparisons between numerical and Doppler-echocardiographic results; (a) 
maximum velocity; (b) the mean and the maximum transvalvular pressure gradients 
(TPG). 
  







Figure 2.5 Comparison of platelets paths downstream of the valve during the deceleration 
phase a) 0-50 ms after the peak b) 100-150 ms after the peak and for different 
percentages of dysfunction. 
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Platelet paths changed significantly with increasing the percentage of BMHV 
dysfunction. As a consequence of the development of a more vortical flow due to bottom 
leaflet dysfunction, platelets might be trapped in some regions of the domain, thereby 
increasing significantly the residential time. Hence, even if the turbulent shear stress is 
generally low in these regions, the level of platelets activation may be significant. 
Another important result is that with increasing valve dysfunction, the platelets on the 
normal leaflet side travel farther in the domain (due to a higher velocity), except for a 
100% dysfunction, where the interaction between the upper-lateral jet and the 
recirculation zone developed downstream of the valve limits the displacement of the 
platelets by redirecting them to the regions of lower turbulent shear stresses.   
Figure 2.6a and 2.6b show the level of platelet activation as calculated by (   t ) 
during the deceleration phase (100 ms to 150 ms after the peak of the systolic phase) for 
particles released near the outer edge of the upper leaflet (normal leaflet) (Fig. 2.6a) and 
near the inner edge of the bottom leaflet (dysfunctional leaflet) (Fig. 2.6b). The level of 
platelets activation was determined for different dysfunction severities (from 0% to 
100%). For the particles released near the outer edge of the upper leaflet, the highest level 
of activation was obtained for a 75% dysfunction (8.7 dyne.s/cm
2
). This value is five 
times higher than that of the healthy case and it is higher than that of a fully closed 
leaflet. This can be explained by the fact that in a partially blocked leaflet, the platelets 
were trapped in the wake of the trailing edge where the level of shear stress is relatively 
high. On the other hand, in the fully dysfunctional leaflet, the platelets escaped away 
from the wake of the leaflet region to the core of the flow where the shear stress is 
relatively lower. 
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2.4 Discussion  
2.4.1 Clinical Diagnosis  
In the clinical setting, the evaluation of BMHV function is usually performed using 
Doppler echocardiography. Maximum velocity of the forward flow is measured by 
positioning the ultrasound wave beam through the valve. Only the instantaneous 
maximum velocity is used to determine the transvalvular pressure gradient and effective 
orifice area (EOA). However, in order to get accurate measurements, it is very important 
to align the ultrasound beam with the flow direction (Doppler Effect). Furthermore, 
clinicians usually tend to position the axis of the Doppler beam within the center of the 
valve. In the case of normally functioning BHMV, the maximum velocity is similar in the 
3 orifices. However, in the case of a completely dysfunctional leaflet, the flow is shifted 
towards the normal leaflet and the maximal velocity is through the lateral orifice along 
the wall. The Doppler beam aligned on the central orifice may miss the maximum 
velocity that is displaced laterally. This may explain the discrepancy between peak 
gradient measured by Doppler echocardiography and that obtained by numerical 
simulation in the case of severe prosthesis dysfunction (Fig. 2.4). 
 
In contrast, the difference in TPGmean was the highest in the healthy case. This could be 
explained by the fact that the fluid-structure interaction has not been simulated in this 
study, and as the TPGmean is calculated through the whole systolic phase, as a result, a 
percentage of error is expected during the opening and closure of the valve. For this 
reason, the effect of neglecting FSI on TPGmean is less significant with higher percentage 
of dysfunction.   








Figure 2.6 Platelets level of activation during the deceleration phase (100-150 ms after 
the peak) for different percentages of dysfunction. (a) Particles released from the upper 
valve orifice, (b) Particles released from the lower valve orifice.  
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Consequently, clinicians should pay attention to seek the maximum velocity by shifting 
the Doppler beam from central to lateral, and this should be done on both sides 
 
2.4.2 TSS and Residential Time (Platelet Activation) 
Turbulent shear stress level and position will change in the case of a dysfunctional 
BMHV. In 50% dysfunction of one leaflet, the relatively high shear stress areas covered 
most of the domain downstream of the valve. Therefore, the number of blood elements 
that will be exposed to high shear stress level is higher in the case of partially 
dysfunctional leaflet than in the case of normal function or of a leaflet blocked in the 
fully closed position. Furthermore, the increase in the number and scale of vortices 
downstream of the valve will lead to an increase in the residential time of blood elements 
in these high shear stress regions. As a result, the level of platelet activation and 
thrombus formation can increase significantly. Interestingly, this study shows that the 
level of platelet activation is markedly increased at moderate levels of dysfunction, which 
may predispose to worsening of thrombosis or de novo thrombosis. Hence, this could 
lead to a vicious cycle where the abnormal flow pattern caused by mild or moderate 
degrees of dysfunction creates favorable conditions for thrombus formation on the valve, 
which in turn worsens the valve dysfunction.  
It is worth to mention that the potential of blood hemolysis was consider early in the 
study conducted by smadi et al. (2009) where they concluded that the maximum shear 
stress in the presence of 100% dysfunction (205 Pa) did not reach the hemolytic threshold 
(400 N/m
2
 and 1 ms) that suggested by Sallam and Hwang (1984). Therefore, only 
platelet activation state was depicted. 
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2.5 Conclusion  
In conclusion, this study showed that the flow upstream and downstream of a 
dysfunctional mechanical heart valve was highly influenced by dysfunction severity and 
this resulted in discrepancies between the Doppler echocardiographic and numerically 
derived transvalvular pressure gradients. Moreover, the flow downstream of the 
dysfunctional valve was characterized by abnormally elevated shear stresses and large-
scale vortices. These characteristics can predispose to blood components damage. 
Finally, from a clinical point of view, clinicians should try, when possible, to check the 
maximal velocity position not only at the central orifice but also through the lateral 
orifices. Finding the maximal velocity in the lateral orifice could be an indication of 
valve dysfunction.  





Bileaflet Prosthetic Heart Valve Disease: Numerical Approach 
Using 3-D Fluid-Structure Interaction Model with Realistic 
Aortic Root 
 
Certain assumptions were made in the numerical simulations in chapter two, including 
two-dimensional flow (2-D), immobile leaflets, and non-realistic valsalva sinuses. The 
impact of such simplifications on clinically-related outcomes has not been clarified yet. 
In this chapter, three-dimensional (3-D) blood flow in the presence of fluid-structure 
interactions was simulated. Realistic aortic root geometry was created for this purpose.  
 
3.1 Introduction 
Valve stenosis or incompetence at severe levels reduce the performance of the heart and 
place additional stress and strain upon it. In many cases, surgical replacement of the 
diseased valve with a bioprosthetic or mechanical heart valve is necessary to restore 
normal heart function. Due to their longer lifespan, around 50% of valve replacements 
worldwide are mechanical heart valves. Usually, a patient with a Bileaflet Mechanical 
Heart Valve (BMHV) must take lifelong anticoagulant medication due to the risk of 
thromboembolic complications, which can restrict leaflet movement. Another potential 
complication associated with mechanical valves is pannus formation (Montorsi et al., 
2003). Non-invasive diagnosis and evaluation of the severity of BMHV dysfunction 
using Doppler echocardiography and magnetic resonance imaging is not straight forward, 
usually due to theoretical, technical or accessibility limitations. It is important, therefore, 
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to investigate the flow downstream of a dysfunctional BMHV and to investigate the 
limitations of current diagnostic techniques.   
Most numerical and experimental studies on BMHVs have focused on normal 
functioning valves with high emphasis on the velocity field, transvalvular pressure drop 
and blood components damage. Numerically, different approaches were considered. For 
the geometry, 2-D and 3-D analysis were conducted with simple or realistic aortic root. 
Also, a simple aortic arch (straight tube) and a realistic curved arch were considered. In 
addition, both steady and pulsatile flows were simulated. Generally, steady flow was used 
to study flow at the peak of the systolic phase, while pulsatile flow was concentrated 
more on the whole cardiac cycle with more than one of the three phases (acceleration, 
peak and deceleration phases) (Yoganathan et al., 2004; Bluestein et al., 2010).   
Recently, Direct Numerical Simulations (DNS) with full FSI were performed by Dasi et 
al. (2007), Nobili et al. (2008) and De Tullio et al. (2009). However, the high 
computational cost required for DNS, limits its applicability to practical clinical 
problems. 
Finally, few studies investigated the blood flow through an obstructed BMHV. 
Baumgartner et al. (1993) showed, in vitro, that a dysfunctional BMHV (Carbomedics 
valve with one leaflet blocked) led to an increase in energy loss through the valve 
resulting in a significant discrepancy between catheter and Doppler echocardiographic 
transvalvular pressure gradients. This reduction resulted from a less significant pressure 
recovery downstream of the dysfunctional BMHV. This was confirmed numerically, in a 
recent study performed by Smadi et al. (2009) where the authors also suggested new 
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diagnostic parameters to investigate non-invasively the severity of BMHV dysfunction 
using Doppler echocardiography and magnetic resonance imaging.  
In the current study, blood flow patterns downstream of healthy and dysfunctional 
BMHVs is investigated by conducting 3-D FSI simulations and using realistic aortic 
roots. In addition, the development of coherent structures is investigated. Clinically, the 
maximum pressure gradient is compared to 2-D numerical simulation and in vitro 
measurements.  
 
3.2 Numerical Method 
A 3-D model for 25 mm St. Jude Medical Hemodynamic Plus valve was created and 
implanted in a 3-D realistic aortic root. The restriction on leaflet motion was applied only 
to one of the two leaflets (Smadi et al., 2010). The position of the leaflet was varied from 
the fully opened position (normal function) to the fully closed position (100% 
dysfunction) with one intermediate position (50% dysfunction) (Fig. 3.1).  
The dysfunction was present only during the leaflet opening phase (stenosis) while the 
leaflet is functioning properly during the closure (no extra regurgitation). This is 
consistent with in vivo findings by Aoyagi et al. (2000). 
The simulations were performed under unsteady conditions with an experimental 
pulsatile flow as the inlet condition (Fig. 3.1) and ambient pressure at the outlet. The 
mean cardiac output was 5 L/min and the heart rate was 70 bpm (systolic phase duration 
0.3 s). Blood was simulated as a Newtonian fluid with a density of 1060 kg/m
3
 and a 
dynamic viscosity of 0.0035 Pa s. The assumption of a Newtonian fluid behavior is 
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realistic for blood flow in large arteries such as the aorta (Morris et al., 2005). The inlet 
conditions corresponded to a Remax = 8934, Reaverage= 3820 and Womersley number = 
16.2. 
3.2.1 Turbulent-FSI Approach 
The current simulation was carried out using commercial software (FLUENT) and 
adapted the Arbitrary Lagrangian Eulerian method (ALE) for re-configuring the mesh of 
the fluid domain after the solid part (the leaflets) moved to a new position. Meshing the 
geometry was done by GAMBIT 2.4 (Fluent Inc.) and by using 2.5 million elements. 
This method was used and validated by Dumont et al. (2004), Dumont et al. (2007) and 






Figure 3.1 The geometry (high right corner) and the mesh quality (lower part) of 25 mm 
St. Jude hemodynamic Plus (SJHP) with the instantaneous velocity (high left corner) as 
an inlet condition. 
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In the present study, two-equations transitional k  model was used to capture the 
laminar-transitional-turbulent flow phenomenon (See chapter two). A second-order 
upwind scheme was selected to be the discretization scheme for the convection terms of 
all governing equations. For all transient calculations, a second-order temporal 
discretization scheme was used. The mass-momentum equations were solved using the 
PISO solver and all results converged to residuals of < 10
-4
.  Unsteady simulations 
generally required 5-10 iterations per time step. Moreover, additional care was taken 
close to the wall and leaflet surfaces to maintain y
+
 << 1. The time step was set to 0.05 
ms and two cycles were simulated before starting extraction of the results. 
The motion for the leaflets is assigned and controlled by an external subroutine based on 
experimental data extracted from a high-speed camera. The angular velocity for the 
leaflets was kept the same for all cases. The full nonlinear fluid-structure interaction was 
not considered.  Moreover, the scope of the current study was to evaluate the influence of 
valve dysfunction on the blood flow downstream of the MHV and to compare the healthy 
and the dysfunctional cases with each other.   
3.3 Results and Discussion 
3.3.1 Velocity Contours 
Figure 3.2 shows axial velocity contours for three different percentages of dysfunction 
and at two different instants. In the healthy model (0% dysfunction), the orientation of the 
valve leaflets in the flow field created two wakes and three jets (one central and two 
laterals). Also, a circulation zone within the sinus area was detected and represented with 
a negative value for the axial velocity.  
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The strength of rotation within the sinus area was proportional to the percentage of 
dysfunction. The negative axial velocity magnitude reached the maximum with the 100% 
dysfunction case (Vaxial= -1.5 m/s). Moreover, more circulation zones appeared with 
increased dysfunction severity.  
Introduction of a 50% dysfunction to one leaflet significantly disturbed the flow 
downstream of the MHV. Although the three jets still existed, the velocity profile 
distribution was different from the healthy model. The central and upper lateral jets 
moved closer to each other by shifting the central jet peak velocity towards the upper 
lateral side, while the lower lateral jet moved towards the wall. For 100% dysfunction, 
the flow behavior is close to the 50% dysfunction case except with only two dominant 
central and upper lateral jets instead of the three jets.  It was clear that the central 
common flow is no longer dominant in the presence of the dysfunction and the lateral 
orifices gained greater importance as the majority of the flow passeed through one of 
them. 
The maximal velocity increased dramatically (from ~ 2.3  m/s for healthy case to ~ 4 m/s 
for 100% dysfunction), which in turn increased the Doppler peak pressure gradient ( from 
21 mmHg to 64 mmHg). However, this dramatic change in pressure gradient was not 
clinically sufficient to confirm the presence of valve obstruction as other factors could 
lead to the same result (i.e., high flowrate, left ventricle outflow obstruction and 
prosthesis patient mismatch).  




Figure 3.2 Contours for velocity magnitude through the bileaflet valve for different percentage of dysfunctions at two time instants (at 
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3.3.2 Coherent Structures 
Figure 3.3 shows the isosurface considering Q-criterion downstream of the valve for 
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.   
At the peak of the systolic phase, for the healthy case, three major vortex rings were 
observed within the three sinuses. This is consistent with the findings in the literature. 
However, introduction of the dysfunction significantly disturbed the flow downstream of 
the valve and the coherent structures were dominant through the entir aortic root. In the 
case of 100% dysfunction, the vortex structures traveled for the longest distance 
downstream of the valve compared to the other two cases. In the case of 50% 
dysfunction, the vortex structures covered more area within the sinuses compared to the 
other cases. In general, in healthy BMHVs, the maximum viscous and shear stresses were 
found at the peak instant and downstream of the trailing edge of the two leaflets where 
vortex shedding (von Kármán Vortex Street) occurs (Ge et al., 2007). On the other hand, 
in the dysfunctional BMHVs, the vortical flow covered a larger area. As a consequence, 
blood elements remained for longer periods in the region of elevated shear stress. 
Therefore, platelet activation and/or red blood cell damage could occur.   
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As the coherent structures in the partially dysfunctional valve (50%) were more dominant 
compared to the completely dysfunctional one (100%), the partially dysfunctional 
bileaflet MHV could be developed to a severe case (100% dysfunction) at a relatively 
high rate and within a short period. Therefore, detecting the dysfunction at early stages is 
crucial and any delay in diagnosis could have life threatening consequences. 
 
An isosurface of Q criterion with a value of 5000 s
-1
 was chosen to depict the coherent 
structure during the deceleration phase just before the closure starts. Although, the 
strength of the coherent structure seemed to be decreasing, the disorganized vortical 
structure persisted. This can be attributed to the destabilizing effect of the deceleration 
phase (Dasi et al., 2007). However, the disorganized or chaotic-like coherent structure 
was more dominant in both cases of dysfunctional BMHV compared to the healthy one. 
 
3.3.3 Velocity Magnitude (Two vs. Three Velocity Components) 
Figure 3.4 shows the discrepancy between using the three velocity components and using 
only the two in-plane velocity components to calculate the velocity magnitude. In the 
current study, only, B-datum plane is presented where the maximum discrepancy was 
found. In normally functioning BMHV, a minor discrepancy was found in the sinus area, 
which is in a good agreement with the findings of Kaminsky et al. (2007). However, in 
the presence of dysfunction, the discrepancy was more significant and covered larger 
areas (the central area between leaflets and the area downstream of the sinuses).  




              











Figure 3.4 The difference between the two-component and three-component velocity 
magnitude (V(u,v,w) and V(u,w)) at the central plane (B-datum) and the peak systole. 
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This discrepancy between 2-D and 3-D velocity magnitude might be explained by the 
presence and evolution of coherent structures downstream of BMHVs. The travelling 
path for the coherent structures at some regions was out of plane and volumetric as 
shown in fig. 3.3..  This, in turn, explains the increases in the magnitude of out of plane 
velocity component and affects the accuracy of 2-D assumption. Therefore, the maximum 
discrepancy between 2-D and 3-D velocity magnitude was proportional to the strength 
and presence of coherent structures. It is important to mention that the level of 
discrepancy between 2-D and 3-D velocity magnitudes was proportional to the 
percentage of valve dysfunction and considering 3-D PIV is important especially when 
the dysfunctional mechanical heart valve is the scope of the study.  
 
3.4 Conclusion 
In conclusion, this study showed that the blood flow downstream of BMHV is strongly 
three-dimensional and time dependent, especially with the existence of valve dysfunction. 
Therefore, with the presence of valve dysfunction, pulsatile 3-D simulations should be 
adapted when the evolution of the vortical structure downstream of the BMHV is the 
objective of the study. As depicted above, the lateral flow is dominant in the presence of 
BMHV dysfunction. However, the two lateral orifices were not included in the 
calculations or taken into account in the process of clinical evaluation. Hence, the 
physical flow through the complete BMHV is not accurately represented in the current 
evaluation. Therefore, revisiting the assumptions and the theories behind the current 
clinical method is critical in order to include the flow through the two lateral orifices and 
to investigate its influence on the measurements’ accuracy.  






Performance of Doppler-echocardiographic Parameters for the 
Detection of Aortic Mechanical Prosthetic Valve Dysfunction 
 
Numerical simulations (chapters 2 and 3) revealed that the flow downstream of the 
dysfunctional valve was characterized by abnormally elevated shear stresses and large-
scale vortices. These characteristics can predispose to blood components damage. And 
early detection of prosthetic valve dysfunction could be, then, a key factor for optimal 
medical management.  
In this chapter, in vitro and in vivo studies were performed to evaluate the performance of 
different Doppler-echocardiographic parameters suggested by the American Society of 
Echocardiography (ASE) guidelines, to identify dysfunction of mechanical prosthetic 
valve in the aortic position. 
 
4.1 Introduction 
Replacing an aortic stenotic native heart valve with a prosthetic heart valve is the ultimate 
solution for symptomatic patients with severe aortic valve stenosis. Despite the marked 
improvement in prosthetic heart valve design and functionality, thromboembolism, 
structural failure, endocarditis and hemolysis are still possible complications. In such 
case, the native heart valve disease is replaced by a “prosthetic heart valve disease” 
(Vesey and Otto, 2004; Rahimtoola, 2010). The reported incidence of such serious and 
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life-threatening complications is between 0.2-6% (Montorsi et al., 2003; Aoyagi et al., 
2000).  Early detection of prosthetic valve dysfunction is then a key factor for successful 
treatment (i.e., heparin, fibrinolysis and reoperation) (Roudaut, 2007).  
Transthoracic Doppler Echocardiography (TTE) is the primary screening technique to 
evaluate prosthetic valve dysfunction. However, visualization of the prosthetic valve, in 
many cases, is limited especially in aortic position (Khandheria et al.; 1991, Mohr-
Kahaly et al., 1993; Maslow et al., 2000; Aslam et al., 2007). The assessment mainly 
relies, therefore, on hemodynamic parameters (aortic peak Doppler velocity, mean 
transvalvular pressure gradient, effective orifice area (EOA) and Doppler velocity index 
(DVI)) (Bach, 2010; Zoghbi et al., 2009; Vesey and Otto, 2004). 
Recently, the American Society of Echocardiography (ASE) published its first guidelines 
and standards document about the assessment of prosthetic heart valve performance. 
Different cutoff values were suggested for the diagnosis of aortic valve dysfunction. (i.e., 
peak Doppler velocity > 3 m/s, mean transvalvular pressure gradient > 20 mmHg, 
Doppler velocity index < 0.3, effective orifice area < 1.2 cm
2
, aortic flow acceleration 
time > 80 ms). However, these fixed cutoff values suggested by ASE guidlines might not 
allow an accurate detection of prosthetic heart valve dysfunction under several conditions 
depending on valve type, valve size and transvalvular flowrate (Baumgratner 2009; Hage 
and Nanda, 2009; Aoyagi et al., 2000; Montorsi et al., 2003). Furthermore, current ASE 
guidelines do not differentiate between bioprosthetic and mechanical heart valves 
(MHV).  While, the hemodynamic of bioprosthetic heart valves is close to the 
hemodynamic of native heart valves, the hemodynamic of MHVs is less physiological 
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(i.e. multiple jets, localized high gradient, pressure recovery, mechanism of opening and 
closure) (Baumgartner et al., 1992, Pibarot and Dumesnil, 2009).  
The objective of this study is to evaluate under controlled experimental conditions the 
potential limitations of the parameters and cutoff values suggested by ASE guidelines. 
For this purpose extensive in vitro and retrospective in vivo studies were conducted on 
two commercially available bileaflet MHVs (St. Jude and On-X) with different sizes and 
for several flowrate conditions.  
 
4.2 Methods 
4.2.1 In Vitro Study 
Model. BMHVs were mounted in an in vitro mock flow model already described and 
validated (Garcia et al., 2004) (Fig. 4.1). Briefly, the model is mainly made up of a 
reservoir, a compliant aortic chamber and a valve resistance. The flow was provided by a 
computer controlled DC motor coupled to a gear pump (Vi-CORR, Viking Pump). The 
left ventricular outflow tract and the aorta were both circular and rigid and their size was 
adjusted to be equal to the nominal size of the BMHV under evaluation. The compliant 
chamber was located immediately downstream of the proximal rigid aorta. The fluid was 
composed of 2/3 water and 1/3 of glycerol so that its density (1080 kg/m
3
) and viscosity 
(3.5 cP) were similar to those of blood under high shear rate conditions. The ventricular 
and aortic pressures were measured with Millar catheters (model MPC 500, accuracy 
0.5% full scale) under a sampling frequency of 1000 Hz. For each experiment, 10 cycles 
were recorded and the average was used to calculate the hemodynamic parameters. 
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Test protocol. Doppler echocardiographic measurements were performed on seven 
BMHVs: 4 different sizes of St. Jude HP aortic valves (21, 23, 25 and 27 mm) and 3 
different sizes of On-X aortic valves (21, 23 and 25 mm). The dysfunction of the BMHV 
was introduced by restricting the movement of only one leaflet. This is because such 
condition is more difficult to detect clinically than when both leaflets have restricted 
motion (Montorsi et al., 2003). The position of the leaflet was varied from fully opened 
position (0% dysfunction) to fully closed position (100% dysfunction) with one 
intermediate position (50% dysfunction). All BMHVs were tested under five different 
transvalvular flowrates (3 to 7 L/min), corresponding to  stroke volumes of 30 to 120 mL 
at a fixed heart rate of 70 bpm (ejection phase: 0.3 s). Aortic systolic and diastolic 
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Echocardiography.  Doppler echocardiographic velocity measurements were performed 
in all cases using a Sonos 5500 (Philips Medical Systems/Agilent Technologies, 
Andover, Massachusetts) with a probe of 2.25 MHz. For measuring peak transvalvular 
velocity, the probe was placed at different locations on the measurement window to 
obtain the highest possible peak Doppler velocity reading through the three orifices of 
BMHV (one central and two lateral orifices). In order to avoid aliasing, the continuous-
wave Doppler mode was used. The measurements were performed over 3 cycles and 
averaged. Peak Doppler velocity, mean transvalvular pressure gradients (determined 
using simplified Bernoulli equation), Doppler EOA (estimated using continuity equation) 
were evaluated for all BMHVs with 0%, 50% and 100% percentage of dysfunction. Peak 
flow velocity and Velocity Time Integral (VTILVOT) in the Left Ventricular Outflow Tract 
(LVOT) was measured approximately 0.5 cm upstream from the prosthetic valve using 
pulsed-wave Doppler mode. The stroke volume was calculated as the product of the 
cross-sectional area of the LVOT and VTILVOT. 
4.2.2 In Vivo Study 
Patient Population. From March 2005 to July 2010, 31 patients were referred to 
cinefluoroscopy in the Quebec Heart and Lung Institute for the evaluation of aortic 
prosthetic heart valve performance. From this cohort, we included in the present study 
only the patients who had aortic BMHV and had their fluoroscopy test within two weeks 
from echocardiography evaluation. Among this cohort, 7 patients, with normally 
functioning prosthetic valves (as evaluated by cinefluoroscopy) were excluded from this 
study as Doppler measurements seemed not accurate.  
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 The final cohort consisted then of 17 patients. These patients were then further 
subdivided into 2 groups depending on whether they had a normally functioning valve (n 
= 13) (Table. 4.1) or a valve dysfunction (in one or both leaflets, n = 4) (Table. 4.2). In 
our center, only patients with suspected obstruction (high mean pressure gradient 
(TPGmean > 20 mmHg), low EOA (EOA < 1 cm
2
), or obstruction visualization by 2-D 
echocardiography are referred to a fluoroscopy test. The fluoroscopy test was considered 
to give a definite answer about the presence and severity of valve obstruction. 
Echocardiography and Cinefluoroscopy.   Doppler echocardiographic velocity 
measurements were obtained by placing the transducer in the apical position. Peak flow 
velocity in the left ventricular outflow tract was measured approximately 0.5 cm 
upstream from the prosthetic valve. Cinefluoroscopy was performed to obtain a tangential 
view of the implanted BMHV. For each patient, the maximum opening and closing 
angles were determined by averaging three consequent cardiac cycles. In this study the 
determination of the opening and closing angles were successfully achieved in all the 17 
patients.  
Inter-observer variability: To evaluate the inter-observer variability related to the in vitro 
study, all the measurements were repeated by two blinded observers with the use of the 
same experimental setup for SJHP21 and On-X 21.  
 
Statistical Analysis.  Results are expressed as mean ± SD. Variability was expressed as 
mean percent error, calculated as the absolute difference between the two observations 
divided by the mean of the observations and expressed as percent. 
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1 21-mm ST 2.1 69 2.41 15.4   1.28 0.41 
2 25-mm ST 2.2 88 3.1 25   1.60 0.44 
3 25-mm ST 2.4 68 2.04 9   2.13 0.44 
4 25-mm ST 2.55 76 2.14 9.3   2.06 0.43 
5 25-mm ST 2.3 79 2.15 9   1.88 0.40 
 Carbomedics Top  Hat 
6 21-mm 2.1 87 3.51 27 1.23 0.34 
7 23-mm 2.3 113 3.45 25 1.77         0.38 
8 23-mm 2.2 114 3.75 30 1.90 0.40 
9 23-mm 2.2 69 1.81 7     1.76 0.45 
10 25-mm 2.4 107 2.89 24    1.78 0.36 
 ADVANTAGE 
11 21-mm 1.9 77 2.8 13    1.39 0.44 
 On-X 
12 19-mm 1.9 77 2.49 13   1.39         0.44 
13 23-mm 2.25 84 1.87 7.36     2.20         0.62 
Hp, Hemodynamic Plus; ST, Standard 
 
 





























 2.2 61 
3.26 20 0.97 0.22 






 1.9 47 
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2.1 94 4.08 41 1.14 0.29 
   Hp, Hemodynamic Plus; ST, Standard 
 
 




4.3.1 In Vitro Results 
Peak Doppler Velocity  
Figure 4.2 shows, for both types of BMHVs (St. Jude, On-X), the variation in peak 
Doppler velocity as a function of flowrate, valve size and percentage of dysfunction. As 
expected, peak Doppler velocity magnitude was proportional to transvalvular flowrate 
and inversely proportional to valve size.                                                                                                                                                                        
For the majority (83%) of healthy cases (0% dysfunction), peak Doppler velocity 
magnitude did not exceed the peak Doppler velocity magnitude of 3 m/s (the suggested 
ASE threshold for possible dysfunction). Only the peak Doppler velocity downstream of 
the smaller valves: SJHP21 (3.8 m/s) and On-X21 (3.27 m/s) exceeded ASE guidelines 
threshold. After introducing a 50% dysfunction to one leaflet, the majority (71%) of peak 
Doppler velocity values still did not exceed ASE threshold, with the exception of 21 mm 
and 23 mm valve sizes (for flowrate > 6 L/min). After introducing a 100% dysfunction to 
one leaflet, the majority (70%) of peak Doppler velocity values measured through SJHP 
valves exceeded 3 m/s as well as all (100%) peak Doppler velocity values for On-X. The 
highest peak Doppler velocity measured for SJHP and On-X was 5.6 and 6 m/s, 
respectively.  
 
Mean Transvalvular Pressure Gradient 
Figure 4.3 shows, for both types of BMHVs (St. Jude, On-X), the variation of mean 
transvalvular pressure gradient (TPGmean) as a function of flowrate, valve size and 
percentage of dysfunction.  






Figure 4.2 Measured peak Doppler velocity grouped by prosthetic valves’ type, 
dysfunction and size.  
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As expected, TPGmean was strongly flow dependent. It was also inversely proportional to 
valve size. For the majority of healthy cases (0% dysfunction), TPGmean magnitude did 
not exceed 20 mmHg (the suggested ASE threshold for possible valve dysfunction). Only 
TPGmean of SJHP 21 mm and On-X 21 mm at high cardiac output (7 L/min) reached up to 
22 mmHg and 26.6 mmHg, respectively.  
After introducing a 50% dysfunction to one leaflet, the majority (74%) of TPGmean 
measured still did not exceed 20 mmHg. Only TPGmean for SJHP and On-X with sizes of 
21 mm and 23 mm exceeded 20 mmHg at normal and high cardiac flowrate conditions 
(flowrate ≥ 5L/min). It is worth noting that none of 0% and 50% dysfunction cases 
exceeded the higher limit of ASE for TPGmean (35 mmHg). 
 After introducing a 100% dysfunction to one leaflet, TPGmean for the majority (65%) of 
SJHP valves and all (100%) of On-X valves exceeded the ASE guidelines for lower 
cutoff value (20 mmHg). The highest TPGmean measured were 64.0 mmHg and 73.6 
mmHg for SJHP-21 mm and On-X 21 mm, respectively. While one leaflet was 
completely blocked, TPGmean for the majority (80%) of SJHP valves did not exceed the 
ASE guidelines for higher cutoff value (35 mmHg). Interestingly, On-X valves showed 
an opposite trend and TPGmean for the majority (53%) of 100% dysfunction cases 
exceeded 35 mmHg.   
Doppler Velocity Index (DVI) 
Figure 4.4 shows, for both types of BMHVs (St. Jude, On-X), the variation of Doppler 
velocity index as a function of flowrate, valve size and percentage of dysfunction, valve 
size. For SJHP valves (normal and dysfunctional), there was no strong correlation (R = 
0.02) between valve size and DVI. 





Figure 4.3 Measured mean pressure gradient grouped by prosthetic valves’ type, 
dysfunction and size. 
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Whereas, for On-X valves, DVI negatively correlated with valve size (R = -0.89).  
For healthy cases (0% dysfunction), DVI ranged between 0.54 and 0.48 (mean, 0.52 ± 
0.014) for SJHP valves and ranged between 0.6 and 0.45 (mean, 0.52 ± 0.05) for On-X 
valves. With 50% dysfunction, DVI ranged between 0.41 and 0.47 (mean, 0.44 ± 0.02, p 
< 0.001, compared to healthy case) for SJHP and ranged between 0.37 and 0.47 (mean, 
0.41 ± 0.03, p < 0.001, compared to healthy case) for On-X. For all cases with 50% 
dysfunction, DVI did not reach ASE guidelines upper limit (DVI = 0.3) for possible 
dysfunction. With 100% dysfunction on one leaflet, DVI decreased significantly ranging 
between 0.29 and 0.34 (mean, 0.31 ± 0.017, p < 0.001, compared to healthy case) for 
SJHP and between 0.24 and 0.29 (mean, 0.265 ± 0.014, p < 0.001, compared to healthy 
case) for On-X.  All DVI values for both SJHP and On-X with 100% dysfunction were 
lower than 0.3. However, none (0%) of the values for SJHP and only 20% of values for 
On-X reached ASE guidelines lower limit indicating significant valve dysfunction (DVI 
< 0.25). 
Effective Orifice Area  
Figure 4.5 shows the variation of valve EOA as a function of flowrate, valve size and 
percentage of severity.  As expected, EOA for mechanical heart valves demonstrated no 
significant variation with flowrate. The values of EOA were only a function of valve size 
and percentage of valve dysfunction. For healthy cases (0% dysfunction), EOA ranged 
between 1.84 cm
2
 and 3.10 cm
2
 (mean, 2.38 ± 0.40 cm
2





 (mean, 2.28 ± 0.31 cm
2
) for On-X valves.  
 
 









Figure 4.4 In vitro Doppler velocity index, calculated as the ratio of peak velocity in the 
left ventricle outflow tract to that of the transprosthetic peak velocity in 0% dysfunction, 
50% dysfunction and 100% dysfunction of SJHP (left) and On-X (right) prosthetic valves 
and for different cardiac outputs. Bars, mean ± SD of the measured values each valve 
size. 









Figure 4.5 In vitro effective orifice area (cm
2
) in 0% dysfunction, 50% dysfunction, and 
100% dysfunction of SJHP (upper) and On-X (lower) prosthetic valves and for different 
cardiac outputs. Bars, mean ± SD of the measured values each valve size. 
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With 50% dysfunction, EOA decreased and ranged between 1.40 cm
2
 and 2.55 cm
2
 
(mean, 1.99 ± 0.29 cm
2
, p < 0.001, compared to healthy case) for SJHP valves, and 
between 1.19 cm
2
 and 2.26 cm
2
 (mean, 1.76 ± 0.37 cm
2
, p < 0.001, compared to healthy 
case) for On-X valves. None of 50% dysfunction cases of SJHP and On-X valves reached 
ASE guidelines EOA cutoff value for possible dysfunction (EOA = 1.2 cm
2
). With 100% 
dysfunction in one leaflet, further decrease in EOA was achieved. EOA values ranged 
between 0.96 cm
2
 and 1.90 cm
2
 (mean, 1.46 ± 0.27 cm
2
, p < 0.001, compared to healthy 




 (mean, 1.14 ± 0.22 cm
2
, p < 
0.001, compared to healthy case) for On-X valves. Only 37% of EOA values for 100% 
dysfunction cases were lower than 1.2 cm
2
, and 5.7% of EOA values of 100% 
dysfunction cases were lower than ASE guidelines EOA cutoff value for significant 
dysfunction (EOA = 0.8 cm
2
). 
Sensitivity and Specificity Analysis  
Sensitivity and specificity analysis are used to measure how often the correct diagnosis 
occurs in dysfunctional and normal BMHVs.  The sensitivity of one diagnosis parameter 
is the probability that the dysfunction is diagnosed given that the patient has an actual 
BMHV dysfunction.  And the specificity is the probability that the there is no dysfunction 
is diagnosed given that the patient has normally functioning BMHV. 
Sensitivity and specificity analysis was conducted in two different ways: 1) considering 
two groups: healthy (0% dysfunction) and dysfunctional (including both 50% and 100% 
dysfunction). The results are displayed in Table 4.3; 2) considering two extreme groups: 
healthy (0% dysfunction) and dysfunctional (including 100% dysfunction and excluding 
50 % dysfunction). The results are displayed in Table 4.4.   
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 When considering healthy (0% dysfunction) and dysfunctional valves (including both 
50% and 100% dysfunction), all the parameters suggested by ASE guidelines have a 
relatively high specificity.  The lowest specificity was for peak Doppler velocity with 
82.9%. However, their sensitivity was relatively low. EOA ≤  0.8 cm
2 
and DVI ≤  0.25 
criterions showed the lowest sensitivity (2.9% and 4.3%, respectively) and Vmax  ≥ 3m/s 
criterion showed the highest sensitivity with only 57.1%, EOA ≤  1.2 cm
2
 showed a 
sensitivity of 21.4%. Interestingly, when considered in this analysis the criterion 
suggested by (Wang  et al., 1995, Girard et al., 2001, Pibarot and Dumesnil, 2009): a 
prosthetic heart valve is considered as dysfunction if the EOA measured ≤ EOA normal – 
SD, the sensitivity reached  61.3%. Normal EOA values for most prosthetic valve and 
their standard deviations are tabulated in ASE guidelines and standards document. Also 
considering DVI ≤ 0.35, as suggested by Pibarot and Dumesnil 2009, improved the 
sensitivity (50%).  
Now, when considering only healthy valves (0% dysfunction) and valves with 100% 
dysfunction and excluding the 50% cases, there was a significant increase in sensitivity 
and specificity for all parameters. EOA ≤ 0.8 cm
2 
and DVI ≤ 0.25 criterions still showed 
the lowest sensitivity (5.7% and 8.6%, respectively). Both EOA ≤ EOA normal – SD and 
DVI ≤ 0.35 showed the highest sensitivity (100%). Also, peak Doppler velocity showed 
high sensitivity (82.9 %). 
Measurement variability 
Inter-observer variability for peak LVOT Velocity, peak transaortic velocity, TPGmean, 
and EOA, was 1.8 ± 1.3, 2.4 ± 1.3, 5.6 ± 4.4, and 2.9 ± 2.2, respectively.  
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Table 4.4 Sensitivity and specificity analysis for different echo Doppler parameters 
(excluding 50% dysfunction cases). 
 
Diagnosis criteria for dysfunction Sensitivity (%) Specificity (%) 
Vmax ≥ 4m/s 28.6% 100% 
Vmax ≥ 3m/s 57.1% 82.9% 
TPGmean ≥ 35 mmHg 18.6% 100% 
TPGmean ≥ 20 mmHg 48.6% 88.6% 
DVI ≤ 0.35 50.0% 100% 
DVI ≤ 0.3 34.3% 100% 
DVI ≤ 0.25 4.3% 100% 
EOA ≤ 1.2 cm2 21.4% 100% 
EOA ≤ 0.8 cm2 2.9% 100% 
EOA ≤ EOAnormal - SD 61.3% 100% 
Diagnosis criteria for dysfunction Sensitivity (%) Specificity (%) 
Vmax ≥ 4m/s 51.4% 100% 
Vmax ≥ 3m/s 82.9 % 82.9% 
TPGmean ≥ 35 mmHg 31.4% 100% 
TPGmean ≥ 20 mmHg 77.1% 88.6% 
DVI ≤ 0.35 100.0% 100% 
DVI ≤ 0.3 71.4% 100% 
DVI ≤ 0.25 8.6% 100% 
EOA ≤ 1.2 cm2 40.0% 100% 
EOA ≤ 0.8 cm2 5.7% 100% 
EOA ≤ EOAnormal - SD 100% 100% 
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4.3.2 In Vivo Results 
 Some overlap in values of Doppler-derived parametrs was observed in each of normal 
and dysfunctional BMHVs groups as shown in figure 4.6. 
Peak Doppler velocity and TPGmean was significantly higher in dysfunctional valves 
when compared to normal valves (2.85 ± 0.89 vs. 3.7 ± 0.46 m/s) and (30 ± 12 vs. 20 ± 
13 mmHg), respectively (see Tables 4.3 and 4.4). It should be noted, however that peak 
Doppler velocity ranged from 1.81 m/s to 3.75 m/s for healthy valves and from 3.26 m/s 
to 4.3 m/s for dysfunctional valves, leading to an overlap between the intervals. This was 
the same for TPGmean (healthy valves: 7 to 57 mmHg; dysfunctional valves: 17 to 42 
mmHg).  DVI was significantly higher in healthy valve compared to dysfunctional valves 
(0.41 ± 0.08 vs. 0.26 ± 0.07).  However, DVI for dysfunctional valve ranged between 
0.18 and 0.35.  EOA for healthy valves was significantly higher than the EOA for 
dysfunctional valves (1.7 ± 0.3 cm
2
 vs. 1.05 ± 0.37 cm
2
). However, EOA ranged from 2.2 
cm
2
 to 1.23 cm
2
 for healthy valves and from 1.56 cm
2
 to 0.52 cm
2
 for dysfunctional 
valves, showing a certain overlap between the intervals.  
 
4.4 Discussion 
4.4.1 Peak Doppler Velocity and Mean Transvalvular Pressure Gradient  
The most recent ASE guidelines and standards suggest fixed threshold values for the 
detection of prosthetic valve dysfunction. A peak Doppler velocity equal or higher than 3 
m/s or mean transvalvular pressure gradient equal or higher than 20 mmHg should be, 
following these guidelines, an indicator of possible valve dysfunction.  
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The sensitivity analysis shows, based on the current guidelines for cutoff values, the 
difficulty of detecting the cases of 50% dysfunction (mild to moderate stenosis). 
However, it has already been demonstrated that Doppler-derived velocities and pressure 
gradients are strongly dependent on transvalvular flowrate, left ventricular function, valve 
size, and valve type (Baumgartner et al., 1990; Bottio et al., 2004).  As a consequence, 
especially at low flowrate conditions, the sensitivity of peak Doppler velocity and 
TPGmean for the detection of valve dysfunctionis expected to be low. It was shown (fig. 
4.6) that some dysfunctional BMHVs had peak Doppler velocity and values lower than 
the ASE suggested thresholds. This was mainly the case at low cardiac output and for 
relatively large valve size. These findings are in agreement with Aoyagi et al. (2000) 
where a wide range, with significant overlap, of values for peak Doppler velocities and 
TPGmean was found for normal and dysfunctional BMHVs.  
 
4.4.2 Doppler Velocity Index 
Since DVI calculation does not rely on the determination of LVOT area or on the 
determination of valve size and type, it has been postulated that DVI is flow independent 
(Chafizadeh and Zoghbi 1991; Bach 2010). Few studies reported DVI values for 
dysfunctional BMHVs (Chafizadeh and Zoghbi, 1991; Aoyagi et al., 2000).  Chafizadeh 
and Zoghbi (1991) found that in three severely dysfunctional BMHVs (EOA = 0.43 ± 
0.07 cm
2
), DVI value was lower than 0.25. Aoyagi et al. (2000) investigated 16 
obstructed BMHVs with mild to severe dysfunction and did not find DVI values lower 
than 0.25.  In the current in vitro study, DVI showed a slow response to valve 
dysfunction and only under severe cases (100% dysfunction); DVI was found lower than 
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0.25. This led to a very low sensitivity: 4.3% with all cases and 8.6% when 50% 
dysfunction was excluded.  Increasing DVI limit to 0.3 allowed a significant 
improvement in its sensitivity up to 34.3% for all cases and 71.4% when 50% 
dysfunction was excluded. Interestingly, by increasing DVI limit to 0.35 (Pibarot and 
Dumesnil, 2009; Aoyagi et al., 2000), DVI sensitivity reached up to 50% for all cases and 
100% when 50% dysfunction was excluded. 
Another important point is that since DVI relies on the upstream velocity, for a specific 
transvalvular flowrate and valve size, different LVOT areas will lead to different values 
of DVI (fig.4.7). Indeed, a large LVOT area will result in smaller upstream velocities and 
therefore smaller DVIs even for healthy valves. Similarly, any narrowing in the LVOT 
area will might lead to large DVIs even in the presence of dysfunction (See for example 
Patients #16 and #17 in Table 4.4). The relation between DVI and LVOT area is depicted 
in figure 4.7 for normally functioning SJHP 21 mm and SJHP 27 mm BMHVs.     
 
4.4.3 Effective Orifice Area  
It has already been demonstrated that valve EOA, mainly for BHMVs, is flow 
independent for a large range of flow variations (Baumgartner et al., 1992; Bech-Hanssen 
et al., 2001).  However, EOA is highly dependent on valve design and valve size or valve 
geometrical orifice areas. As a consequence, using a constant threshold (EOA ≤ 1.2 cm2) 
for the detection of BMHV obstruction using Doppler derived EOA will be limited. One 
way to overcome this limitation is to consider valve-specific EOA thresholds. In this 
study, considering for each valve type and size its normal EOA reference value minus 
one standard deviation, as previously suggested (Wang  al., 1995; Girard et al., 2001; 
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Pibarot and Dumesnil 2009) as a threshold resulted in a very high sensitivity of 84.5% for 
all cases.  Normal reference values and their standard deviations are tabulated in ASE 
guidelines and standards document (Zoghbi et al., 2009). Reference values can also be 




Figure 4.7 The effect of LVOT narrowing or dilatation on Doppler velocity index. 
Narrowing of LVOT diameter with the implantation of normal aortic prosthetic SJHP27 
valve ( ), and Dilatation of LVOT diameter with the implantation of normal aortic 
prosthetic SJHP21 ( ). 
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4.4.4 Low Cardiac Output State 
In the current in vitro study, including, only, low flowrate conditions (3-4 L/min) in the 
sensitivity analysis affected mainly flow dependent parameters (peak velocity and mean 
gradient).  By including all cases, the sensitivity dropped from 57.1% to 32.1% and from 
48.6% to 25% for peak Doppler velocity and mean transvalvular pressure gradient, 
respectively. The same trend persists when only 0% dysfunction and 100% dysfunction 
were included (50% dysfunction was excluded), as the sensitivity dropped from 82.9% to 
64.3% and from 77.1% to 50% for peak Doppler velocity and mean transvalvular 
pressure gradient, respectively. Regardless the selection criterion (including or excluding 
50% dysfunction cases), the sensitivity for both parameters was 100%.  
However, the sensitivity and specificity did not change for DVI and EOA parameters 
(flow independent).  
 
4.5 Conclusion 
In the current study, good agreement was fond between in vitro and in vivo concluded 
results. Sensitivity of the fixed cut-off values of different Doppler-echocardiographic 
diagnosis parameters suggested by the American Society of Echocardiography (ASE) 
guidelines was relatively low. In addition, some overlap in values of Doppler-derived 
parametrs was observed in each of normal and dysfunctional BMHVs.  
At low cardiac output, the measured flow dependent parameters (i.e., peak velocity and 
mean pressure gradient) did not exceed, mostly, the cut-off values which in turn could 
affect the accuracy of the detection of valve dysfunction. Therefore, when using peak 
Doppler velocity and mean transvalvular pressure gradient for evaluating mechanical 
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heart valve performance, valve type, valve size and flowrate conditions have to be 
considered.   
Despite the fact that DVI is flow independent and simple to measure (no need to measure 
the diameter of the LV outflow tract), Doppler velocity index results should be 
interpreted with caution since they highly depend on LVOT area.  
Considering reference effective orifice area minus one standard deviation as a cut-off 
value for a suspected valve dysfunction, as suggested by Pibarot and Dumesnil (2009), is 
a more stable and robust parameter for evaluating mechanical heart valve dysfunction. 
  







Theoretical Prediction of the Hemodynamic Performance of 
Bileaflet Mechanical Heart Valves 
 
 
We demonstrated in the previous chapter that the fixed cut-off values for Doppler-derived 
parameters have relatively low sensitivity in detecting prosthetic valve dysfunction. 
Therefore, in this chapter, we propose a mathematical model capable of predicting the 
normal reference values of Doppler-derived parameters by considering flow conditions, 
valve size, and valve type. The theoretical results are validated against in vitro results. 
Moreover, in vivo data from a combined echocardiography/fluoroscopy study were 




Nowadays, 7% of individuals above the age of 65 have a significant aortic stenosis. The 
number of heart valve replacements will dramatically increase in the coming years 
(Chenzbraun, 2010).  Prosthetic heart valve dysfunction, in most cases, is lethal, and an 
early diagnosis for prosthetic valve dysfunction is essential for better outcome and 
successful treatment (i.e., heparin, fibrinolysis and reoperation) (Roudaut et al., 2007; 
Aoyagi et al., 2000).  
Doppler echocardiography, cinefluoroscopy, and computed tomography (CT) are the 
most commonly used modalities for the assessment of prosthetic heart valve 
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performance. Due to the risks associated with X-ray exposure, Doppler/echocardiography 
is routinely used as a first choice in the evaluation of prosthetic heart valve performance. 
Only patients suspected of prosthetic valve dysfunction in Doppler/echocardiography are 
sent to cinefluoroscopy or computed tomography (CT) for visualization of prosthetic 
valve leaflet morphology and mobility (Montorsi et al., 2003; Cianciulli et al., 2005; 
LaBounty et al., 2009). However, in the aortic position, and in many cases, the clear 
visualization of aortic prosthetic valves using Transthoracic Doppler Echocardiography 
(TTE) and/or Transesophageal Doppler Echocardiography (TEE) is limited due to intense 
echo reverberations and shadowing caused by valve components (Khandheria et al., 
1991; Mohr-Kahaly et al., 1993; Maslow et al., 2000; Aslam et al., 2007). Therefore, the 
prosthetic valve evaluation process, using TTE as a first choice modality, can only rely 
on Doppler-derived parameters (peak velocity/gradient, mean pressure gradient, Effective 
Orifice Area (EOA) and Doppler Velocity Index (DVI)) (Bach, 2010; Zoghbi et al., 2009; 
and Vesey and Otto, 2004). The recently published guidelines and standards by the 
American Society of Echocardiography (ASE) emphasized on the use of Doppler-derived 
parameters for the evaluation of aortic prosthetic valves (Zoghbi et al., 2009). For 
prosthetic valves in the aortic position, the guidelines suggested an algorithm using 
constant cut-off values for the previously mentioned Doppler-derived parameters not 
considering flow conditions, valve size and valve type.  
We demonstrated in the previous chapter that the fixed cut-off values have a relatively 
low sensitivity in detecting valve dysfunction, especially for peak velocity and pressure 
gradient. Although the EOA reference value for each valve size and type was listed in the 
guidelines, the listed EOA values, in many cases, are inversely proportional to the valve 
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size (the larger the valve size the lower the EOA value) which is inconsistent with the 
fundamentals of fluid mechanics.  In addition, the large standard deviation (over 30%) 
widens the range of expected normal reference value of a specific valve and hence 
reduces diagnostic accuracy.  
A comprehensive study in precisely controlled environments was conducted to 
theoretically predict the normal reference values of Doppler-derived parameters by 
considering flow conditions, valve size, and valve type. Moreover, in vivo data from a 
combined echocardiography/fluoroscopy study were extracted and analyzed to validate 
the in vitro findings.  
 
5.2 Methods Used for the Validation of the Proposed Theoretical 
Parameters 
 
5.2.1 Experimental Setup 
Model. BMHVs were mounted in an in vitro mock flow model previously described and 
validated (Garcia et al., 2003) (Fig. 5.1). The model is mainly made up of a reservoir, a 
compliant aortic chamber and a valve resistance. The flow was provided by a computer 
controlled DC motor coupled to a gear pump (Vi-CORR, Viking Pump). The left 
ventricular outflow tract and the aorta were both circular and rigid and their size was 
adjusted to be equal to the nominal size of the implanted valve. The compliant chamber 
was located immediately downstream of the proximal rigid aorta. The fluid was 
composed of 2/3 water and 1/3 glycerol so that its density (1080 kg/m
3
) and viscosity (3.5 
cP) were similar to that of blood under high shear rate conditions. The flowrate was 
measured by an electromagnetic flow-meter (Cliniflow II, Carolina Medical Electronics, 
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accuracy 0.5% full scale) and the ventricular and aortic pressures were measured with 
Millar catheters (model MPC 500, accuracy 0.5% full scale) under a sampling frequency 
of 1000 Hz. For each experiment, 10 cycles were recorded and the average was used to 
calculate the hemodynamic parameters. All valves were tested under five different 
transvalvular flowrates (3-7 L/min), corresponding to a stroke volume of 30-100 mL at a 
fixed heart rate of 70 bpm (ejection phase: 0.3 s). Systolic and diastolic pressures were 
maintained under normal physiological conditions: 120 mmHg and 80 mmHg, 
respectively.  
 
Test protocol. In order to investigate the accuracy of conventional Doppler-
echocardiographic measurements in detecting BMHV dysfunction and to validate ASE 
suggested reference values, Doppler echocardiographic measurements were performed in 
a mock flow model incorporating seven BMHVs (4 different sizes of St. Jude HP aortic 
valves (21 mm-27 mm) and 3 different sizes of On-X aortic valves (21mm-25mm)) under 
a wide range of cardiac outputs (3-7 L/min) and with various degrees of dysfunction. The 
dysfunction of the prosthetic valve was introduced by restricting the movement of only 
one leaflet. This is because it is more difficult to detect when compared to the situation 
where both leaflets have restricted motion (Montorsi et al., 2003). The position of the 
leaflet was varied from the fully opened position (0% dysfunction) to the fully closed 
position (100% dysfunction) with one intermediate position (50% dysfunction). 
 
Echocardiography.  Doppler echocardiographic velocity measurements were performed 
in all cases using a Sonos 5500 (Philips Medical Systems/Agilent Technologies, 
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Andover, Massachusetts) with a probe of 2.25 MHz. The probe was placed at different 
locations on the measurement window to obtain the highest possible peak velocity 
reading through the three BMHV orifices (one central and two lateral orifices). In order 
to avoid aliasing, the continuous-wave Doppler mode was used. The measurements were 
performed over three cycles and averaged. Peak Doppler-echocardiographic velocity, 
mean transvalvular pressure gradients (determined using simplified Bernoulli equation) 
and prosthetic EOA (estimated using continuity equation) were evaluated for the BMHVs 
with 0%, 50% and 100% dysfunction. Inter-observer variability for different parameters 
was evaluated by recording the measurements of all SJHP21 and On-X 21 cases by 2 of 
the authors (Table 5.1). Their observations were then compared with one another. 
Variability was expressed as mean percent error, calculated as the absolute difference 
between the two observations divided by the mean of the observations and expressed as a 
percentage. 
 
Table 5.1 Variability of in vitro extracted Doppler-derived parameters for St. Jude and 
On-X Prosthetic Valves  
 Interobserver 
 (%) 
Peak LVOT Velocity  m/s 1.8 ± 1.3 
Peak transprosthetic Velocity m/s 2.4 ± 1.3 
EOA cm
2 
2.9 ± 2.2 
TPGmean mmHg 5.6 ± 4.4 


























Figure 5.1 Sketch for the custom-made cardiac simulator, and the maximum opening 
position for the leaflets. 
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5.2.2 In Vivo Data 
Patient Population. From March 2005 to July 2010, 31 patients underwent both a 
Doppler-echocardiographic exam and a valve cinefluoroscopy within a period of 2 weeks 
at the Quebec Heart and Lung Institute. The patients were referred to cinefluoroscopy due 
to suspected valve dysfunction on the Doppler-echocardiographic exam. Among these 
patients, 4 had a valve dysfunction confirmed by the visualization of abnormal motion of 
one or two leaflets on cinefluoroscopy. Seven patients with normally functioning 
prosthetic valve at cinefluoroscopy were excluded as Doppler-echocardiographic data 
was incomplete.  The final cohort thus consisted of 17 patients: 13 with normal valve 
function (Table 5.3) and 4 with valve dysfunction (Table 5.4).  
 
Echocardiography and Cinefluoroscopy.   In echocardiography, the magnitude of the 
velocity across the prosthetic valves was obtained by placing the transducer in the apical 
position. For continuous wave Doppler measurements, the transmitted beam was placed 
as close to the perpendicular plane of the valve ring as possible. Doppler velocity in the 
left ventricular outflow tract was measured approximately 0.5 cm upstream from the 
prosthetic valve. Cinefluoroscopy was performed to obtain a tangential view of the 
implanted prosthetic valve. The maximum opening and closing angles were determined 
by averaging 3 consequent cardiac cycles for each patient. In this study the determination 
of the opening and closing angles was possible in all 17 patients. 
 
5.2.3 Mathematical Model for Proposed Parameters 
In the current model, theoretical reference values for Doppler-derived parameters  
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(e.g., peak velocity, mean velocity, TPGmean, and EOA), in normally functioning 
bileaflet mechanical heart valves, are predicted. Any significant difference between the 
theoretically predicted and accurately measured parameter can be interpreted as a 
dysfunction in the valve.  The current theoretical predictions follow the standard clinical 
settings by considering the flow through the central orifice (between the two leaflets) for 
calculating Doppler-derived parameters. 
 
5.2.3.1 Predicted Peak and Mean Velocities  
The main assumption in the current approach is that the fraction of total flow crossing a 
specific orifice (central or lateral) is proportional to its area over the geometrical orifice 
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A is the area of the 
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Figure 5.2 Schematic representation for blood flow through bileaflet mechanical heart 
valve, where Qpeak-LVOT is peak systolic flowrate (L/min) at the left ventricle outflow tract 
location, QC is the flowrate (L/min) through the central orifice, and QL is the flowrate 
(L/min) through the lateral orifice.  
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                                                                  (5.3)  
From equation 5.3, we can predict peak transvalvular velocity as well as the mean 














































                                                            (5.7) 
 
where                   is the predicted peak transvalvular velocity (m/s), 
                 is the predicted mean transvalvular velocity (m/s);            is the 
measured peak LVOT flowrate (m
3
/s),            is the measured mean LVOT 
flowrate (m
3
/s), and       is the measured LVOT diameter (m).  
It is obvious that equations 5.5 and 5.6 rely, mainly, on accurate LVOT measurements 
(i.e., diameter, velocity spectrum), and prosthetic valve GOA to accurately predict the 
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5.2.3.2 Predicted Mean Pressure Gradient  
Doppler derived pressure gradient is traditionally calculated as an average of 

































considering the mean velocity for calculating TPGmean (TPGmean = 4*V
2
mean) will 












                                                          (5.8) 
However, this percentage changes according to the type of commercial echocardiography 
machine used for the measurements. In the current study Sonos 5500 echocardiography 
machine was used and the constant value was 0.85.  
 
5.2.3.3 Predicted Effective Orifice Area (EOApredicted):       

















EOA                                                                                          (5.10) 
 
5.3 Results 
In the current results, a contraction coefficient of 0.7 was adapted for the theoretical 
prediction of normal reference values of Doppler-derived parameters.  The previously 
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reported values for the contraction coefficient ranged from 0.6 to 0.8 (Cc ≈ 0.6-0.8) (Izzat 
et al., 1996; Chandas et al., 2000; Kadir et al., 2001; Bech-Hanssen et al., 2001; Guivier-
Curien et al., 2009).  However, different BMHVs have different designs (i.e., different 
maximum opening angle). Moreover, reported  in vivo  maximum opening angles might 
be lower compared to in vitro ones (Cianciulli et al., 2005). To compensate for such 
limitations, an additional 20% of the predicted values were considered to estimate the in 
vivo cut-off values of Doppler derived parameters.  
VPeak cut-off value = VPeak-Predicted
 
+ 20 % VPeak-Predicted 
TPGmean cut-off value = TPGmean-predicted + 20 % TPGmean-predicted 
EOA cut-off value = EOAPredicted – 20 % EOAPredicted 
 
5.3.1 Validation Against In Vitro Data 
Peak and Mean Velocities 
Figures 5.3 and 5.4 show, for different sizes of SJHP and On-X BMHVs, variation in 
peak and mean Doppler velocities as a function of flowrate and percentage of BMHV 
dysfunction. Theoretically predicted peak and mean Doppler velocities for normally 
functioning BMHVs (0% dysfunction) are also shown.  
Peak and mean Doppler velocity magnitudes were proportional to transvalvular flowrate 
and inversely proportional to valve size. The highest measured peak Doppler velocity in 
normally functioning valves was achieved for the smallest valve size and highest flowrate 
and reached up to 3.8 m/s and 3.27 m/s for SJHP21 and On-X21, respectively. Moreover, 
the highest measured mean Doppler velocity in normally functioning valves was 
achieved at the smallest valve size and highest flowrate and reached up to 2.30 m/s and 
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2.18 m/s for SJHP21 and On-X21, respectively. Furthermore, peak and mean Doppler 
velocities were proportional to the percentage of dysfunction. The highest peak velocity 
was found with the presence of 100% dysfunction and reached up to 5.6 and 6 m/s for 
SJHP21 and On-X21, respectively. The highest mean Doppler velocity was 3.7 m/s and 
3.97 m/s for SJHP21 and On-X21, respectively. 
Introducing 50% of dysfunction to one leaflet (25% reduction in total GOA), did not 
significantly alter the peak and mean Doppler velocity values. Compared to normal cases, 
peak and mean Doppler velocities of 50% dysfunctional cases increased by 17.00% ± 
10.72% and 18.15% ± 9.10%, respectively.  
Introducing 100% dysfunction to one leaflet (50% reduction in total GOA) significantly 
increased the peak and mean Doppler velocity by 71.8% ± 31.14% and 71.92% ± 
26.55%, respectively.  
As shown in Figures 5.5.a and 5.6.a, the correlation between theoretical and in vitro 
measurements of peak/mean Doppler velocities was excellent (R
2
 = 0.96 and R
2 
= 0.93, 
respectively). In addition, good agreement was observed between predicted and measured 
peak and mean velocity values where fitting lines almost coincide with the line of 
equality. The good agreement was also observed in the Bland-Altman plots (Figures 5.5b 
















Figure 5.3 Measured peak transvalvular velocity for different flowrates and different 
percentages of valve dysfunction. Theoretically predicted peak velocity of normally 
functioning valve (0% dysfunction) for different flowrates is also plotted.   
  














Figure 5.4 Measured mean transvalvular velocity for different flowrates and different 
percentages of valve dysfunction. Theoretically predicted mean velocity of normally 
functioning valve (0% dysfunction) for different flowrates is also plotted. 
  














Figure 5.5 (a) In vitro correlations between predicted and measured peak Doppler 
velocity. (b) Differences between predicted and measured peak Doppler velocity are 
presented on a Bland-Altman plot. 









Figure 5.6 (a) In vitro correlations between predicted and measured mean Doppler 
velocity. (b) Differences between predicted and measured mean Doppler velocity are 
presented on a Bland-Altman plot. 
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Mean Pressure Gradient 
Figure 5.7 shows, for the largest and the smallest sizes of SJHP and On-X BMHVs, 
variation in TPGmean as a function of flowrate and percentage of dysfunction. The 
theoretically predicted TPGmean for normally functioning BMHV (0% dysfunction) is also 
shown.  
The TPGmean magnitude was proportional to transvalvular flowrate and inversely 
proportional to valve size. The highest measured TPGmean in normally functioning valves 
was achieved at the smallest valve size and highest flowrate and reached up to 26.6 
mmHg and 22.0 mmHg for SJHP21 and On-X21, respectively. Furthermore, TPGmean 
was proportional to percentage of dysfunction. The highest TPGmean was found with the 
presence of 100% dysfunction and reached up to 64 mmHg and 73.63 mmHg for SJHP21 
and On-X21, respectively.  
Introducing 50% dysfunction to one leaflet (25% reduction in total GOA), did not 
significantly alter TPGmean values.  Relative to normal cases, TPGmean increased by 40% ± 
23.27% in the presence of 50% dysfunction,. Introducing 100% dysfunction to one leaflet 
(50% reduction in total GOA) significantly increased the percent difference for TPGmean 
up to 210.36% ± 103.20%. 
As shown in Figure 5.8a, the correlation between theoretical and in vitro TPGmean was 
excellent (R
2
 = 0.94). Also, good agreement was found between predicted and measured 
TPGmean values where the fitting lines almost coincide with the line of equality. The good 
agreement could be shown in the Bland-Altman plots as well (Figure 5.8b).  
 
 









Figure 5.7 Measured TPGmean for different flowrates and different percentages of 
dysfunction. The theoretically predicted TPGmean of normally functioning valve (0% 
dysfunction) for different flowrates is also plotted. 
 
 










Figure 5.8 (a) In vitro correlation between predicted and measured TPGmean; (b) 
Differences between predicted and measured TPGmean are presented on a Bland-Altman 
plot. 
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Effective Orifice Area (EOA)  
Table 5.2 shows good agreement between current in vitro EOA values and the theoretical 
EOA, as well as the reported in vivo EOA values in the literature (Zoghbi et al. 2009; 
Pibarot and Dumesnil 2009). The reference values in these articles are extracted from 
different previous publications and not the results of one comprehensive study. 
Figure 5.9 shows, for different sizes of SJHP and On-X BMHVs, the variation in EOA as 
a function of flowrate and percentage of dysfunction. Also, the theoretical EOA for 
normal-functioning BMHV (0% dysfunction) was shown.  
EOA magnitude was found to be flowrate independent and only proportional to valve 
size and type. The highest measured EOA in normally functioning valves was achieved at 
the largest valve size and reached up to 2.95 ± 0.10 cm
2
 and 2.62 ± 0.19 cm
2
 for SJHP27 
and On-X25, respectively. Furthermore, EOA was inversely proportional to percentage of 
dysfunction. The lowest EOA was found with the presence of 100% dysfunction and 
dropped to 1.06 ± 0.06 cm
2
 and 0.88 ± 0.08 cm
2
 for SJHP21 and On-X21, respectively.  
However, reduction percentage in measured Doppler EOA was close from the reduction 
percentage in GOA. Compared to normal cases, EOA decreased by 17.92% ± 6.1% after 
the introduction of 50% dysfunction. Introducing 100% dysfunction to one leaflet (50% 
reduction in total GOA) decreased the measured Doppler EOA by 41.78% ± 6.48%. 
As shown in Figure 5.10a, the correlation between theoretical and in vitro EOA was high 
(R
2
 = 0.88). Also, good agreement was found between predicted and measured EOA 
values as shown in the Bland-Altman plot (Figure 5.10b).  
 
  






  Table 5.2 Validation of measured EOA normal reference values 
Valve Type * GOA
 Current 
(In vitro ) 
Current 
(Theoretical) 









4.18 2.95 ± 0.10 2.93 
2.8 ± 0.5 
(ST) 
3.2 ± 0.3 (ST) 
SJ-HP25/  SJ-
ST27 
3.56 2.44 ± 0.08 2.50 
2.5 ± 0.4 
(ST) 
2.7 ± 0.6 (ST) 
SJ-HP23/  SJ-
ST25 
3.00 2.16 ± 0.01 2.10 
1.7 ± 0.5 
(HP) 
2.1 ± 0.4 (ST) 
SJ-HP21/  SJ-
ST23 
2.46 1.87 ± 0.02 1.72 
1.8 ± 0.5 
(HP) 
1.5 ± 0.5 (ST) 
ON-X25 4.05 2.62 ± 0.19 2.84 2.4 ± 0.6 2.4 ± 0.8 
ON-X23 3.43 2.00 ± 0.07 2.19 1.9 ± 0.6 2 ± 0.6 
ON-X21 2.80 1.69 ± 0.05 1.96 1.7 ± 0.4 1.7 ± 0.4 
SJHP valve has the same GOA as the SJ-ST, which is one size larger (SJHP25=SJST27) 
  











Figure 5.9 Measured EOA for different flowrates and different percentages of 
dysfunction. The theoretically predicted EOA of normally functioning valves (0% 
dysfunction) for different flowrates is also plotted. 
  














Figure 5.10 (a) In vitro correlations between predicted and measured EOA. (b) 
Differences between predicted and measured EOA are presented on a Bland-Altman plot. 
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5.3.2 Validation Against In-Vivo Data 
Tables 5.3 and 5.4 show the in vivo measured Doppler parameters and their 
corresponding theoretically predicted values (peak velocity, TPGmean, and EOA) for 
normal and dysfunctional BMHVs, respectively. Good correlation (R
2
 = 0.89) was found 
between the predicted and measured peak velocity as shown in Fig. 5.11.a and on the 
Bland-Altman plot in Fig. 5.11b. 
The mean values of the Doppler derived peak velocities and mean pressure gradients of 
dysfunctional valves were 2.85 ± 0.89 m/s and 30 ± 11.6 mmHg, respectively. 
These values were higher than those of normal valves (3.7 ± 0.46 m/s and 19.6 ± 13 
mmHg). However, there was a wide range of peak velocities and gradients, and the peak 
velocity and gradient of some healthy valves was higher than the value for some 
dysfunctional valves. For healthy valves, EOA values ranged between 2.2 and 1.23 
(mean, 1.7 ± 0.3) and were higher than EOA values for dysfunctional valves which 




(mean, 1.05 ± 0.37 cm
2
). However, there was a 
wide range of peak velocities, gradients, DVI and EOA.  
Additional validation against in vivo data for the obstructed St. Jude bilealfet valve, 
extracted from Aoyagi et al. (2001) was also conducted (Table 5.5). The EOA values for 
all listed cases were significantly lower than the suggested cut-off value.  
 
5.4 Discussion 
Early detection of valve dysfunction can save patients from lethal consequences. We 
demonstrated in the previous chapter that the fixed cut-off values for Doppler-derived 
parameters have relatively low sensitivity in detecting valve dysfunction. Although the 
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EOA reference value for each valve size and type was listed in the guidelines, these 
values, in many cases, were not in agreement with the fundamentals of fluid mechanics 
(the larger the valve size, the lower the EOA value!).  In addition, the large standard 
deviation (over 30%) widens the range of expected normal reference values for a specific 
valve and thus reduces the diagnostic accuracy.   
Predicting the normal values of Doppler-derived parameters (peak velocity, mean 
pressure gradient, and EOA) based on flow conditions and valve type, for each patient, 
would be extremely useful in improving the diagnostic accuracy of valve dysfunction. 
 
5.4.1 Velocities and Pressure Gradients 
Velocity and pressure gradients showed strong dependency on flowrate and BMHV size 
(Baumgartner et al., 1992). Of note is that accurate valve size relies on the actual inner 
GOA not the labelled size (Chambers et al., 2003). Therefore, detecting BMHV 
dysfunction using a fixed cut-off value for peak velocity and mean gradient without 
considering flow conditions or valve size/type, as suggested by ASE guidelines, can 
reduce in the sensitivity of diagnosing valve dysfunction.  This is especially important for 
low flowrates through a large BMHV where the peak velocity and mean gradient could 
be less than the cut-off value. In contrast, high flowrate through normally functioning 
small BMHV could elevate the peak velocity and the mean pressure gradient above the 
cut-off values (figs. 5.3, 5.4, and 5.7).  
The theoretically predicted peak velocity and mean pressure gradient proposed in this 
work take into account flowrate and valve size/type. Therefore, each patient can have a 
customized reference value based on the cardiac output and the implanted BMHV. 
   
 






























1 21-mm ST 2.1 69 2.41 2.46 15.4 1.28 1.15 
2 25-mm ST 2.2 88 3.10 2.55 25.0 1.60 1.73 
3 25-mm ST 2.4 68 2.04 2.00 9.0 2.13 1.73 
4 25-mm ST 2.55 76 2.14 2.33 9.3 2.06 1.73 
5 25-mm ST 2.3 79 2.15 1.77 9.0 1.88 1.73 
Carbomedics Top  Hat 
6 21-mm 2.1 87 3.51 2.84 27.0 1.23 1.17 
7 23-mm 2.3 113 3.45 3.01 25.0 1.77 1.43 
8 23-mm 2.2 114 3.75 3.69 30.0 1.90 1.43 
9 23-mm 2.2 69 1.81 2.00 7.0 1.76 1.43 
10 25-mm 2.4 107 2.89 2.33 24.0 1.78 1.77 
ADVANTAGE 
11 21-mm 1.9 77 2.80 2.43 13.0 1.39 1.15 
On-X 
12 19-mm 1.9 77 2.49 2.23 13.0 1.39 1.24 
13 23-mm 2.25 84 1.87 1.91 7.36 2.2 1.92 







   
 
 










































o 2.2 61 0.72 3.26 1.91 20 0.97 1.58 







1.9 47 0.77 4.3 1.25 42 0.52 1.73 







2.3 100 1.15 3.29 1.96 17 1.56 2.34 







2.1 94 1.18 4.08 1.82 41 1.14 2.15 




















Table 5.5 Doppler-derived data for obstructed aortic bileaflet valves (Aoyagi et al., 2000) 
























 3.39 2.50 1.16 1.15 0.33 




 3.5 2.34 0.99 1.15 0.30 




 3.7 2.23 0.80 1.15 0.27 




 4.12 2.31 0.72 1.15 0.25 




 3.38 2.50 0.99 1.15 0.33 
ST, Standard 
  















Figure 5.11 (a) In vivo correlation between predicted and measured peak Doppler 
velocity. (b) Differences between predicted and measured peak Doppler velocity are 
presented on a Bland-Altman plot. 
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It is worth mentioning that accurate LVOT measurements (velocity and diameter) and 
information about the size and type of the implanted BMHV (actual GOA) are essential 
for precise predictions. 
 
5.4.2 Effective Orifice Area 
Equation 5.10 is the original definition of EOA. However, reaching to this fundamental 
definition based on the suggested formulas for the predicted velocity supports the method 
and the assumptions that led to the current theoretically derived parameters.  
Based on in vivo data shown in tables 5.2 and 5.3, EOA cut-off values showed better 
accuracy in differentiating between normal and dysfunctional valves compared to other 
suggested parameters. Moreover, flow independency makes EOA more favourable than 
other Doppler derived parameters in this study. However, precise LVOT measurements 
(LVOT Diameter and VTILVOT) are essential for getting accurate EOA.  
 
5.4.3 Mild to Moderate Severity of Valve Dysfunction (50% Dysfunction)  
Compared to normal cases, introducing 50% dysfunction to on leaflet did not 
significantly elevate the peak velocity, the TPGmean, or the EOA.  The values, as 
percentage increase, were 17% ± 10.7%, 40% ± 23.3%, and 17.9% ± 6.1%, respectively 
(figures 5.3, 5.7, and 5.9). Consequently, accurate diagnosis for cases with 50% valve 
dysfunction can be difficult, especially with the presence of technical measurement errors 
in echocardiography measurements such as misalignment between the ultrasound beam 
and the velocity jet, or inaccurate measurement of the LVOT diameter (Chenzbraun, 
2010). 
 





  a)      
 
b)     
c)     
 
Figure 5.12 Plotted charts show realtionships between peak/mean flowrate and predicted 
Doppler-derived parameters; a) Peak flowrate vs. Peak velocity; b) Mean flowrate vs. 
mean velocity; c) Mean flowrate vs. TPGmean. 
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5.4.4 Charts  
Plotted charts for cut-off values of Doppler derived parameters as a function of flowrate 
and valves size/type could be a practical solution for quick and easy access to the 
information without any further calculations (Fig. 5.12).   
 
5.5   Conclusion   
A reliable and practical mathematical model was proposed for predicting the normal 
reference values of Doppler-derived parameters for BMHVs. The proposed model was 
validated against in vivo and in vitro data in the current study. Moreover, good agreement 
was found between predicted and measured Doppler-derived parameters for normally 
functioning BMHVs. The theoretical model overcomes the shortcomings of the 
parameters suggested by the ASE guidelines as it accounts for flow conditions (LVOT 
measurements), valve size and valve type.  Diagnostic accuracy significantly improved 
using the new theoretical parameters compared to ASE suggested parameters. Moreover, 
the new method improves the evaluation of the performance of BMHVs, not only after 
implantation, but early at the stage of design and manufacturing. 
 
  




Conclusions and Future work 
 
 Conclusions  
In the present study, blood flow dynamics through a dysfunctional bileaflet mechanical 
heart valve and the impact of valve dysfunction on clinical complications and clinical 
practices were investigated. Two dimensional, pulsatile and two-phase flow k-w turbulent 
models as well as 3-D, pulsatile, and FSI k-w turbulence models were used for numerical 
simulation. Numerically, (25 St. Jude hemodynamic Plus) BMHV was tested under 
normal flowrate conditions and for three different levels of dysfunction. A custom-made 
cardiac simulator was built and two different types of BMHVs with 7 different sizes were 
tested at wide range of flowrates and for three different levels of valve dysfunction. 
Moreover, in vivo data, from both echocardiography and cinefluoroscopy tests were 
analyzed for patients who have implanted aortic BMHV. 
 
Numerical simulation for 2-D k-w turbulence models adapting the two-phase flow 
assumption showed that the flow through and downstream of a dysfunctional mechanical 
heart valve was highly influenced by dysfunction severity and this resulted in 
discrepancies between the Doppler echocardiographic and numerically derived 
transvalvular pressure gradients. Moreover, the flow downstream of the dysfunctional 
valve was characterized by abnormally elevated shear stresses and large-scale vortices. 
These characteristics can predispose to blood components damage. Finally, from a 
clinical point of view, clinicians should try, when possible, to check the maximal velocity 
   
112 
 
position not only at the central orifice, but also through the lateral orifices. Finding the 
maximal velocity in the lateral orifice could be an indication of valve dysfunction.  
 
Three-dimensional FSI numerical simulations using k-w turbulence model was conducted 
using approximately 2.5 million elements. Three different levels of dysfunction at normal 
flowrate conditions were simulated. This study showed that the flow nature is strongly 
three dimensional and time dependent, especially in the existence of valve dysfunction. 
Therefore, in the presence of valve dysfunction, the pulsatile 3-D simulation should be 
used when the evolution of the vortical structure downstream of the BMHV is the 
objective of the study. Finally, it appears that 2-D pulsatile simulation was able to depict 
the main flow characteristics that are related to clinical diagnosis (pressure gradient and 
peak velocity). 
 
In vitro and in vivo evaluations for the performance of Doppler-echocardiographic 
parameters for the detection of aortic mechanical prosthetic valve dysfunction were 
performed. Low sensitivity for the detection of valve dysfunction was found in all listed 
Doppler-echocardiographic parameters under the ASE guidelines. This was mainly due to 
considering fixed cut-off values regardless of flow conditions, valve size or valve type. 
Therefore, valve type, valve size and flowrate conditions have to be considered, 
especially when using peak Doppler velocity and mean transvalvular pressure gradient 
for evaluating mechanical heart valve performance.  Doppler velocity index results 
should be interpreted with caution since they also depend on LVOT area. The reference 
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effective orifice area minus one standard deviation is a more stable and robust parameter 
for evaluating mechanical heart valve dysfunction. 
 
A reliable and practical mathematical model was proposed for predicting the normal 
reference values of Doppler-derived parameters for BMHVs. The proposed model was 
validated against in vivo and in vitro data in the current study. Moreover, good agreement 
was found between predicted and measured Doppler-derived parameters for normally 
functioning valves. The theoretical model overcomes the shortcomings of the ASE 
suggested parameters by taking in to account flow conditions (LVOT measurements), 
valve size and valve type.  Diagnostic accuracy significantly improved using the new 
theoretical parameters compared to ASE suggested parameters. Moreover, the new 
method improves the evaluation of the performance of BMHVs, not only after 
implantation, but also early at the stage of design and manufacturing. 
 
Future Work  
Strongly Coupled 3-D FSI Realistic Model 
CFD is a major tool for investigating blood flow through mechanical heart valves. 
Although, up to date, there is no numerical method capable of accurately simulating the 
blood flow through mechanical heart valves under physiological conditions, CFD is 
widely used in this field. Therefore, it will be useful to consider a Direct Numerical 
Simulation (DNS) for blood flow through aortic BMHVs with strongly coupled 3-D FSI 
and using a very dense mesh (>10 million elements) capable of resolving the smallest 
turbulent scale (Kolmogorov scale).  This will allow the study of the opening and closing 
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phases of dysfunctional BMHVs and also getting more precise information about the 
interaction between blood elements and flow field (platelet activation and hemolysis). 
In the current study, a dysfunctional BMHV was studied in the aortic position and the 
same problematic mechanical heart valve was studied in the mitral position as this will 
affect the left ventricle’s diastolic function. 
 
Validation of 3-D FSI Numerical and Echo Doppler Results Using Particle Image 
Velocimetry     
 As flow downstream of the MHV is inherently three dimensional and the systolic part of 
the cardiac cycle (most of our investigations are related to this part) is complete within 
0.3 s, time resolved PIV measurements is needed to capture the flow characteristics 
downstream of the valve. The time resolved PIV measurements will be used as a gold 
standard to validate the numerical simulations and to extract the flow turbulent 
characteristics with the presence of valve dysfunction. 
The same cardiac simulator that was used for the echo Doppler measurements will be 
used for the PIV measurements and under the same conditions. This will allow the 
validation of echo Doppler fluid mechanics assumptions (i.e., flat velocity profile, 
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